Please Wait.....
Report
Biobanking Market by Product (Equipment, Consumables, Software), Services (Virtual), Operation (Automated), Workflow (Storage, Collection, Transport), Sample (Blood, Cell Lines, Nucleic Acids), Application, Ownership, End User - Global Forecast to 2030
Market Report I 2025-08-23 I 492 Pages I MarketsandMarkets
The biobanking market is projected to reach USD 11.82 billion by 2030 from USD 7.65 billion in 2025, at a CAGR of 9.1% during the forecast period. The growing focus on precision medicine and the expanding pipeline for cell and gene therapies are set to significantly fuel the growth of the biobanking market. Precision medicine, which tailors treatments to individual genetic profiles, is increasingly driving the need for high-quality, well-preserved biological samples, as these form the foundation for personalized therapies. Additionally, the growing pipeline for cell and gene therapies is expected to be a major driver for the biobanking market in the coming years. The development of new cell and gene therapies, which often rely on stem cells, gene editing, and other advanced biotechnologies, necessitates storing and managing vast amounts of biological material. Biobanks are essential in supporting these therapies by providing a reliable and standardized platform for sample storage, processing, and distribution.
https://www.marketsandmarkets.com/Images/biobanking-devices-market-Overview.webp
The physical biobanking segment accounted for the largest share of the biobanking services market in 2024.
Based on services, the biobanking market is segmented into physical biobanking, virtual biobanking, and other services. In 2024, the large share of physical biobanking services in the market can be attributed to the essential role they play in sample collection, storage, and preservation under controlled conditions. Physical biobanks offer the infrastructure necessary to store a wide range of biological samples, including blood, tissues, and DNA, in environments such as freezers, cryogenic tanks, and refrigerators, ensuring sample integrity for long-term use. As the demand for high-quality biological specimens grows, driven by advancements in precision medicine and genomics, physical biobanks are crucial for maintaining the stability and accessibility of these samples. Additionally, the ability to provide reliable, on-site sample management and real-time monitoring systems has further cemented the importance of physical biobanks in supporting pharmaceutical, biotechnology, and research sectors.
By ownership, the private/commercial providers segment accounted for the largest share of the market in 2024.
Based on the ownership model, the biobanking services market is segmented into private/commercial providers, academic & research institutional biobanks, national/regional agencies, hybrid/PPP (public-private-partnership) models, and other ownership models. In 2024, the private/commercial providers segment accounted for the largest share of the global biobanking market. The large share of the private/commercial providers model in the biobanking market is primarily driven by the growing demand for high-quality, scalable, and commercially viable biobanking solutions. These providers can offer advanced, state-of-the-art infrastructure and technology for sample storage, processing, and distribution, often tailored to meet the specific needs of pharmaceutical, biotechnology, and clinical research sectors. Commercial providers are also more agile in adopting innovations and expanding their services to meet the evolving demands of precision medicine, genomic research, and clinical trials. Their ability to provide comprehensive, end-to-end biobanking services and focus on efficiency and regulatory compliance has made them essential partners for organizations seeking reliable and standardized biological sample management. As a result, the private/commercial ownership model continues to dominate the market, with private players capturing a significant share.
The US dominated the biobanking market in 2024.
In 2024, the US held a significant share of the North American biobanking market, driven by its advanced healthcare infrastructure, substantial investment in research and development, and leading role in precision medicine. With numerous world-renowned academic institutions, pharmaceutical companies, and research organizations, the US is at the forefront of generating and utilizing biological samples for a wide range of scientific advancements. The growing emphasis on personalized medicine, genomics, and clinical trials has increased the demand for high-quality biobanks in the region. Additionally, favorable regulatory frameworks and substantial public and private funding continue to support the expansion of biobanking services, solidifying the dominant position of the US in the market.
The primary interviews conducted for this report can be categorized as follows:
- By Respondent: Supply-side- 70% and Demand-side 30%
- By Designation: Managers - 45%, CXOs & Directors - 30%, and Executives - 25%
- By Region: North America - 40%, Europe -25%, Asia Pacific -25%, Latin America -5% and the Middle East & Africa- 5%
List of Companies Profiled in the Report:
- Thermo Fisher Scientific Inc. (US)
- Merck KGaA (Germany)
- PHC Holdings Corporation (Japan)
- Becton, Dickinson and Company (BD) (US)
- Qiagen (Germany)
- Merck KGaA (Germany)
- Labcorp (US)
- Eurofins Scientific (Luxembourg)
- Cryoport (US)
- ICON Plc (Ireland)
- Tecan Trading AG (Switzerland)
- Azenta US Inc. (US)
- Avantor, Inc. (US)
- Greiner AG (Austria)
- Amsbio (UK)
- Labcorp (US)
- Eurofins Scientific (Luxembourg)
- Hamilton Company (US)
- BioIVT LLC (US)
- BioKryo (Germany)
- ASKION GmbH (Germany)
- Sopachem (Belgium)
- Froilabo (UK)
- Cureline (US)
- SPT Labtech Ltd (UK)
Research Coverage
This research report categorizes the biobanking market by offerings [products (equipment, consumables), services (physical biobanking, virtual biobanking, other services), software]; workflow (sample collection & storage, sample processing, sample analysis, transport & logistics), operation type (manual, automated), sample type (blood products, solid tissues & organs, stem cell & cell lines, nucleic acids, biological fluids, human waste products), end user- product (biobanks, CROs), end -user services (pharma, biotech & CROs, academic & research institutes), and region (North America, Europe, the Asia Pacific, Latin America, Middle East, and Africa). The report's scope covers detailed information regarding the leading factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the biobanking market. A thorough analysis of the key industry players has provided insights into their business overview, services, products, solutions, key strategies, collaborations, partnerships, and agreements. New launches, collaborations, and acquisitions are the recent developments associated with the biobanking market.
Key Benefits of Buying the Report
The report will help market leaders/new entrants by providing the closest approximations of the revenue numbers for the overall biobanking market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to position their business better and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.
The report provides insights on the following pointers:
- Analysis of key drivers (growing focus on precision medicine & population-genomics programmes, cell- & gene-therapy pipeline expansion, adoption of energy-efficient Ultra Low Temperature(ULT) freezers, end-to-end automation & robotics for physical sample handling and storage), restraints (high upfront capital expenditure, sample quality variability), opportunities ( outsourcing of cryogenic storage to third-party specialists, growing focus on sustainability and green-lab solutions), and challenges (long-term funding stability for public biobanks) influencing the growth of the market.
- Product/Service Development/Innovation: Detailed insights on newly launched products, services of the biobanking market
- Market Development: Comprehensive information about lucrative markets - the report analyzes the market across varied regions.
- Market Diversification: Exhaustive information about new products, services, untapped geographies, recent developments, and investments in the biobanking market
- Competitive Assessment: In-depth assessment of market shares, growth strategies, and product & service offerings of key players including Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), PHC Holdings Corporation (Japan), Becton, Dickinson and Company (BD) (US), Qiagen (Germany), Labcorp (US), Eurofins Scientific (Luxembourg), Cryoport (US). A detailed analysis of the key industry players has been conducted to provide insights into their key strategies, product launches, acquisitions, partnerships, agreements, collaborations, expansions, other recent developments, investment and funding activities, brand/product comparative analysis, and vendor valuation and financial metrics of the biobanking product and service market.
1 INTRODUCTION 46
1.1 STUDY OBJECTIVES 46
1.2 MARKET DEFINITION 46
1.3 STUDY SCOPE 46
1.3.1 BIOBANKING MARKET SEGMENTATION & REGIONAL SCOPE 47
1.3.2 INCLUSIONS & EXCLUSIONS 48
1.3.3 YEARS CONSIDERED 49
1.3.4 CURRENCY CONSIDERED 50
1.4 STAKEHOLDERS 50
1.5 SUMMARY OF CHANGES 50
2 RESEARCH METHODOLOGY 52
2.1 RESEARCH DATA 52
2.1.1 SECONDARY DATA 53
2.1.1.1 Key sources of secondary data 53
2.1.1.2 Key objectives of secondary research 53
2.1.2 PRIMARY DATA 54
2.1.2.1 Breakdown of primaries 54
2.1.2.2 Key objectives of primary research 55
2.2 MARKET ESTIMATION METHODOLOGY 55
2.2.1 GLOBAL MARKET SIZE ESTIMATION, 2024 55
2.2.1.1 Company revenue analysis (bottom-up approach) 55
2.2.1.2 MnM repository analysis 57
2.2.1.3 Primary interviews 58
2.2.1.4 Insights from primary sources 58
2.2.2 SEGMENTAL MARKET ASSESSMENT (TOP-DOWN APPROACH) 58
2.3 MARKET GROWTH RATE FORECAST 60
2.3.1 IMPACT ANALYSIS OF SUPPLY- AND DEMAND-SIDE FACTORS 61
2.3.2 BIOBANKING MARKET: GROWTH ANALYSIS OF MARKET DYNAMICS 62
2.4 DATA TRIANGULATION 62
2.5 STUDY ASSUMPTIONS 63
2.6 RESEARCH LIMITATIONS 64
2.7 RISK ANALYSIS 65
3 EXECUTIVE SUMMARY 66
3.1 KEY INSIGHTS & MARKET HIGHLIGHTS 66
3.2 STRATEGIC IMPERATIVES FOR STAKEHOLDERS 70
3.2.1 BIOBANKING EQUIPMENT MANUFACTURERS 70
3.2.2 BIOBANKING CONSUMABLE MANUFACTURERS 70
3.2.3 BIOBANKING SERVICE PROVIDERS 71
4 PREMIUM INSIGHTS 72
4.1 BIOBANKING MARKET OVERVIEW 72
4.2 NORTH AMERICA: BIOBANKING MARKET, BY OFFERING AND COUNTRY, 2024 73
4.3 BIOBANKING PRODUCTS MARKET SHARE, BY END USER, 2024 73
4.4 BIOBANKING SERVICES MARKET SHARE, BY END USER, 2024 74
4.5 BIOBANKING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 74
5 MARKET OVERVIEW 75
5.1 INTRODUCTION 75
5.2 MARKET DYNAMICS 75
5.2.1 DRIVERS 76
5.2.1.1 Growing focus on precision medicine & population genomics programs 76
5.2.1.2 Expansion of cell & gene therapy pipeline 77
5.2.1.3 Adoption of energy-efficient ULT freezers 77
5.2.1.4 Integration of end-to-end automation & robotics for sample handling & storage 78
5.2.2 RESTRAINTS 78
5.2.2.1 High capital expenditure 78
5.2.2.2 Variability associated with sample quality 79
5.2.3 OPPORTUNITIES 79
5.2.3.1 Outsourcing of activities by SME biopharma companies to third-party specialists 79
5.2.3.2 Increasing focus on sustainability & green-lab solutions 80
5.2.4 CHALLENGES 80
5.2.4.1 Challenges associated with long-term funding stability for public biobanks 80
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES 81
5.3.1 STRATEGIC ANALYSIS OF GROWTH OPPORTUNITIES 81
5.4 PRICING ANALYSIS 82
5.4.1 AVERAGE SELLING PRICE OF BIOBANKING PRODUCTS, BY KEY PLAYER, 2024 82
5.4.2 INDICATIVE PRICING OF BIOBANKING SERVICES, BY SERVICE TYPE, 2024 83
5.4.3 INDICATIVE PRICING TREND FOR BIOBANKING MARKET, BY REGION, 2022?2024 83
5.5 VALUE CHAIN ANALYSIS 84
5.6 ECOSYSTEM ANALYSIS 85
5.6.1 ROLE IN ECOSYSTEM 86
5.6.2 EMERGING BUSINESS MODELS & ECOSYSTEM SHIFT IN BIOBANKING MARKET 88
5.7 PATENT ANALYSIS 88
5.8 LIST OF KEY PATENTS 90
5.9 TECHNOLOGY ANALYSIS 91
5.9.1 KEY TECHNOLOGIES 91
5.9.1.1 Automated sample collection and processing technologies 91
5.9.1.2 Sample analysis technologies 91
5.9.2 COMPLEMENTARY TECHNOLOGIES 92
5.9.2.1 Data management & informatics 92
5.9.2.2 AI & ML in biobanking 92
5.10 KEY CONFERENCES & EVENTS, 2025?2026 93
5.11 REGULATORY ANALYSIS 93
5.11.1 REGULATORY FRAMEWORK 94
5.11.1.1 North America 94
5.11.1.2 Europe 94
5.11.1.3 Asia Pacific 94
5.11.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 95
5.12 TRADE ANALYSIS 96
5.12.1 IMPORT DATA FOR HS CODE 8418, 2020-2024 96
5.12.2 EXPORT DATA FOR HS CODE 8418, 2020-2024 97
5.13 PORTER'S FIVE FORCES ANALYSIS 97
5.13.1 THREAT OF NEW ENTRANTS 98
5.13.2 THREAT OF SUBSTITUTES 99
5.13.3 BARGAINING POWER OF BUYERS 99
5.13.4 BARGAINING POWER OF SUPPLIERS 99
5.13.5 INTENSITY OF COMPETITIVE RIVALRY 99
5.14 KEY STAKEHOLDERS & BUYING CRITERIA 100
5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS 100
5.14.2 KEY BUYING CRITERIA FOR BIOBANKING PRODUCTS, BY END USER 101
5.14.3 KEY BUYING CRITERIA FOR BIOBANKING SERVICES, BY END USER 102
5.14.4 UNMET NEEDS & WHITE SPACES 103
5.15 INVESTMENT & FUNDING SCENARIO 104
5.15.1 VC/PRIVATE EQUITY INVESTMENT TRENDS & STARTUP LANDSCAPE, 2024 105
5.16 IMPACT OF AI/GEN AI ON BIOBANKING MARKET 105
5.16.1 INTRODUCTION 105
5.16.2 USE CASES 105
5.16.3 FUTURE OF AI IN BIOBANKING MARKET ECOSYSTEM 106
5.17 IMPACT OF 2025 US TARIFF ON BIOBANKING MARKET 107
5.17.1 INTRODUCTION 107
5.17.2 KEY TARIFF RATES 107
5.17.3 PRICE IMPACT ANALYSIS 108
5.17.4 KEY IMPACTS ON COUNTRIES/REGIONS 108
5.17.4.1 North America 108
5.17.4.1.1 US 108
5.17.4.2 Europe 109
5.17.4.3 Asia Pacific 109
5.17.5 IMPACT ON END-USE INDUSTRIES 109
5.17.5.1 Biobanks 109
5.17.5.2 CROs 110
6 BIOBANKING MARKET, BY OFFERING 111
6.1 INTRODUCTION 112
6.2 PRODUCTS 113
6.2.1 EQUIPMENT 116
6.2.1.1 Freezers & refrigerators 118
6.2.1.1.1 Storage of blood, DNA, and serum to fuel market growth 118
6.2.1.2 Cryogenic storage systems 121
6.2.1.2.1 Rising demand for cell & gene therapies to fuel market 121
6.2.1.3 Alarm & monitoring systems 124
6.2.1.3.1 Regulatory demand for continuous monitoring to support market growth 124
6.2.1.4 Thawing equipment 126
6.2.1.4.1 Growing demand for CAR-T and mRNA therapies to fuel uptake 126
6.2.1.5 Temperature & humidity control systems 129
6.2.1.5.1 Critical role in maintaining sample integrity to aid adoption 129
6.2.1.6 Other equipment & accessories 132
6.2.2 CONSUMABLES 134
6.2.2.1 Surging sample volumes and recurring demand to drive market 134
6.3 SERVICES 137
6.3.1 OUTSOURCING OF SERVICES TO CROS TO DRIVE MARKET 137
6.4 SOFTWARE 140
6.4.1 GROWING FOCUS ON AUTOMATION TO PROPEL MARKET 140
7 BIOBANKING PRODUCTS MARKET FOR EQUIPMENT, BY OPERATION TYPE 144
7.1 INTRODUCTION 145
7.2 MANUAL OPERATIONS 145
7.2.1 LARGE EXISTING INSTALLED BASE AND NO REQUIREMENT FOR SPECIALIZED LABOR TO DRIVE MARKET 145
7.3 AUTOMATED OPERATIONS 148
7.3.1 INCREASING INNOVATION AND RISING TECHNOLOGICAL ADVANCEMENTS TO PROPEL MARKET 148
8 BIOBANKING PRODUCTS MARKET, BY WORKFLOW 152
8.1 INTRODUCTION 153
8.2 SAMPLE COLLECTION & STORAGE 153
8.2.1 LARGE RESEARCH COHORTS AND SUSTAINABILITY MANDATES TO DRIVE MARKET 153
?
8.3 SAMPLE PROCESSING 156
8.3.1 AUTOMATION DEMAND AND COMPLIANCE RULES TO FUEL MARKET 156
8.4 SAMPLE ANALYSIS 159
8.4.1 HIGH DEMAND FOR ACTIONABLE DATA TO FUEL MARKET 159
8.5 TRANSPORT & LOGISTICS 162
8.5.1 TEMPERATURE-SENSITIVE REQUIREMENTS TO SUPPORT PRODUCTS UPTAKE 162
9 BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE 166
9.1 INTRODUCTION 167
9.2 BLOOD PRODUCTS 167
9.2.1 EASE OF COLLECTION AND ANALYTICAL VERSATILITY TO PROPEL MARKET 167
9.3 SOLID TISSUES & ORGANS 170
9.3.1 GROWTH IN SPATIAL OMICS TO FUEL MARKET 170
9.4 STEM CELLS & CELL LINES 173
9.4.1 ADOPTION OF REGENERATIVE MEDICINE TO BOOST DEMAND 173
9.5 BIOLOGICAL FLUIDS 175
9.5.1 UTILIZATION FOR DISEASE-MECHANISM STUDIES TO FUEL UPTAKE 175
9.6 NUCLEIC ACIDS 178
9.6.1 INTEGRATION OF MULTI-OMICS TO BOOST DEMAND 178
9.7 HUMAN WASTE PRODUCTS 181
9.7.1 APPLICATIONS ACROSS MICROBIOME RESEARCH TO FUEL UPTAKE 181
10 BIOBANKING PRODUCTS MARKET, BY END USER 184
10.1 INTRODUCTION 185
10.2 BIOBANKS 185
10.2.1 GROWING FOCUS ON LIFE SCIENCES & CLINICAL RESEARCH TO BOOST DEMAND 185
10.3 CROS 188
10.3.1 GROWING FOCUS ON BIOMARKER TRIALS AND OUTSOURCING OF SERVICES TO SUPPORT MARKET 188
11 BIOBANKING SERVICES MARKET, BY OWNERSHIP 192
11.1 INTRODUCTION 193
11.2 PRIVATE/COMMERCIAL BIOBANKS 193
11.2.1 TECHNOLOGICALLY ADVANCED INFRASTRUCTURE AND COMPLIANCE OFFERINGS TO PROPEL MARKET 193
11.3 ACADEMIC & RESEARCH INSTITUTION BIOBANKS 196
11.3.1 FAVORABLE FUNDING ACTIVITIES TO BOOST DEMAND 196
11.4 NATIONAL/REGIONAL AGENCIES 199
11.4.1 GOVERNMENT FOCUS ON ADVANCING HEALTHCARE RESEARCH INITIATIVES TO DRIVE MARKET 199
11.5 HYBRID/PPP MODELS 202
11.5.1 HIGH CREDIBILITY AND AGILITY TO SUPPORT MARKET GROWTH 202
11.6 OTHER OWNERSHIP MODELS 205
12 BIOBANKING MARKET, BY APPLICATION 208
12.1 INTRODUCTION 209
12.2 RESEARCH APPLICATIONS 209
12.2.1 LIFE SCIENCE RESEARCH 212
12.2.1.1 Increasing focus on genomics projects to fuel uptake 212
12.2.2 CLINICAL RESEARCH 215
12.2.2.1 Growing regulatory requirements and decentralized & hybrid trials to support market growth 215
12.3 THERAPEUTIC APPLICATIONS 218
12.3.1 GROWING DEMAND FOR CELL & GENE THERAPIES TO PROPEL MARKET 218
12.4 DIAGNOSTIC APPLICATIONS 220
12.4.1 REQUIREMENT OF DISEASE-SPECIFIC SAMPLES TO BOOST DEMAND 220
12.5 OTHER APPLICATIONS 223
13 BIOBANKING SERVICES MARKET, BY TYPE 226
13.1 INTRODUCTION 227
13.2 PHYSICAL BIOBANKING SERVICES 227
13.2.1 MEGA-COHORTS IN ONCOLOGY & POPULATION GENOMICS TO PROPEL MARKET 227
13.3 VIRTUAL BIOBANKING 230
13.3.1 EASE OF SPECIMEN ACCESS FOR END USERS TO DRIVE MARKET 230
13.4 OTHER SERVICES 233
14 BIOBANKING SERVICES MARKET, BY END USER 236
14.1 INTRODUCTION 237
14.2 PHARMA-BIOTECH COMPANIES & CROS 237
14.2.1 EXPANDING DRUG DISCOVERY & DEVELOPMENT PIPELINE TO PROPEL MARKET 237
14.3 ACADEMIC & RESEARCH INSTITUTES 240
14.3.1 ADVANCEMENTS IN RESEARCH AND FAVORABLE GRANTS TO BOOST DEMAND 240
14.4 HOSPITALS & DIAGNOSTIC LABORATORIES 243
14.4.1 USE OF SAMPLES FOR THERAPEUTIC & DIAGNOSTIC PURPOSES TO AID MARKET 243
15 BIOBANKING MARKET, BY REGION 246
15.1 INTRODUCTION 247
15.2 NORTH AMERICA 247
15.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 253
15.2.2 US 254
15.2.2.1 US to dominate North American biobanking market during forecast period 254
15.2.3 CANADA 258
15.2.3.1 Strong public investment with national research networks and collaborations to support disease-focused biobanking 258
15.3 EUROPE 262
15.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 267
15.3.2 GERMANY 268
15.3.2.1 High government funding and focus on advanced clinical research to augment market growth 268
15.3.3 UK 273
15.3.3.1 Presence of large-scale, population-based advanced research infrastructure to propel market growth 273
15.3.4 FRANCE 277
15.3.4.1 Growing focus on quality standards, open science, and international collaboration to support market growth 277
15.3.5 ITALY 281
15.3.5.1 Improved healthcare standards to support biobanking studies in cancer, rare diseases, and personalized medicine healthcare 281
15.3.6 SPAIN 286
15.3.6.1 Adoption of international standards and advanced government-backed infrastructure to aid market growth 286
15.3.7 REST OF EUROPE 290
15.4 ASIA PACIFIC 294
15.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 300
15.4.2 CHINA 301
15.4.2.1 Increased research collaborations and advancements in biobank infrastructure to drive market 301
15.4.3 JAPAN 305
15.4.3.1 Strong genomic research output and focus on AI-driven polygenic risk scoring to boost predictive healthcare innovation 305
15.4.4 INDIA 309
15.4.4.1 National and disease-specific initiatives for advanced precision medicine and healthcare innovation to aid market growth 309
15.4.5 AUSTRALIA 314
15.4.5.1 Increasing national investments in disease-specific, microbiome, and wildlife biobanks to accelerate market growth 314
15.4.6 SOUTH KOREA 318
15.4.6.1 Increased quality standards and more international collaborations to support human and environmental biobanking 318
15.4.7 REST OF ASIA PACIFIC 323
15.5 LATIN AMERICA 327
15.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 332
15.5.2 BRAZIL 333
15.5.2.1 Genetic diversity and large-scale stem cell & genomic initiatives to propel market growth 333
15.5.3 MEXICO 337
15.5.3.1 Favorable initiatives for improving population health research and representation in global genomic databases to drive market 337
15.5.4 REST OF LATIN AMERICA 341
15.6 MIDDLE EAST 346
15.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST 351
15.6.2 GCC COUNTRIES 352
15.6.2.1 Kingdom of Saudi Arabia (KSA) 357
15.6.2.1.1 Investments in automated equipment biobank infrastructure, ISO accreditation, and Vision 2030 to boost market growth 357
15.6.2.2 UAE 361
15.6.2.2.1 Investments in AI-driven robotic biobanking to fuel market growth 361
15.6.2.3 Rest of GCC countries 365
15.6.3 REST OF MIDDLE EAST 371
15.7 AFRICA 376
15.7.1 GROWING STANDARDIZATION EFFORTS, INTERNATIONAL ACCREDITATION, AND CAPACITY-BUILDING TO PROPEL MARKET GROWTH 376
15.7.2 MACROECONOMIC OUTLOOK FOR AFRICA 380
16 COMPETITIVE LANDSCAPE 382
16.1 INTRODUCTION 382
16.2 KEY PLAYERS STRATEGIES/RIGHT TO WIN 382
16.3 REVENUE ANALYSIS, 2020-2024 384
16.3.1 REVENUE ANALYSIS FOR BIOBANKING PRODUCTS, 2020-2024 384
16.3.2 REVENUE ANALYSIS FOR BIOBANKING SERVICES & SOFTWARE, 2020-2024 386
16.4 MARKET SHARE ANALYSIS, 2024 386
16.4.1 MARKET SHARE ANALYSIS FOR BIOBANKING PRODUCTS, 2024 386
16.4.2 MARKET SHARE ANALYSIS FOR BIOBANKING SERVICES & SOFTWARE, 2024 388
16.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 390
16.5.1 STARS 391
16.5.2 EMERGING LEADERS 391
16.5.3 PERVASIVE PLAYERS 391
16.5.4 PARTICIPANTS 391
16.5.5 COMPANY FOOTPRINT, KEY PLAYERS, 2024 393
16.5.5.1 Company footprint 393
16.5.5.2 Region footprint 394
16.5.5.3 Offering footprint 395
16.5.5.4 Sample type footprint 396
16.5.5.5 Workflow footprint 397
16.6 COMPANY EVALUATION MATRIX: START-UPS/SMES, 2024 397
16.6.1 PROGRESSIVE COMPANIES 397
16.6.2 RESPONSIVE COMPANIES 397
16.6.3 DYNAMIC COMPANIES 398
16.6.4 STARTING BLOCKS 398
16.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 399
16.6.5.1 Detailed list of key startups/SMEs 399
16.6.5.2 Competitive benchmarking of startups/ SMEs 400
16.7 COMPANY VALUATION & FINANCIAL METRICS 401
16.7.1 COMPANY VALUATION & FINANCIAL METRICS FOR BIOBANKING PRODUCTS MARKET 401
16.7.1.1 Company valuation 401
16.7.1.2 Financial metrics 401
16.7.2 COMPANY VALUATION & FINANCIAL METRICS FOR BIOBANKING SERVICES & SOFTWARE MARKET 402
16.7.2.1 Company valuation 402
16.7.2.2 Financial metrics 402
16.8 BRAND/PRODUCT COMPARATIVE ANALYSIS 403
16.9 COMPETITIVE SCENARIO 404
16.9.1 PRODUCT/SERVICE/SOLUTION LAUNCHES 404
16.9.2 DEALS 405
16.9.3 EXPANSIONS 406
17 COMPANY PROFILES 407
17.1 KEY PLAYERS 407
17.1.1 THERMO FISHER SCIENTIFIC INC. 407
17.1.1.1 Business overview 407
17.1.1.2 Products/Services/Solutions offered 408
17.1.1.3 Recent developments 414
17.1.1.3.1 Product launches 414
17.1.1.3.2 Deals 415
17.1.1.3.3 Expansions 415
17.1.1.4 MnM view 416
17.1.1.4.1 Key strengths 416
17.1.1.4.2 Strategic choices 416
17.1.1.4.3 Weaknesses & competitive threats 416
17.1.2 PHC HOLDINGS CORPORATION 417
17.1.2.1 Business overview 417
17.1.2.2 Products/Services/Solutions offered 418
17.1.2.3 Recent developments 420
17.1.2.3.1 Product launches 420
17.1.2.4 MnM view 421
17.1.2.4.1 Key strengths 421
17.1.2.4.2 Strategic choices 421
17.1.2.4.3 Weaknesses & competitive threats 421
?
17.1.3 BECTON, DICKINSON AND COMPANY (BD) 422
17.1.3.1 Business overview 422
17.1.3.2 Products/Services/Solutions offered 423
17.1.3.3 Recent developments 425
17.1.3.3.1 Product launches 425
17.1.3.4 MnM view 426
17.1.3.4.1 Key strengths 426
17.1.3.4.2 Strategic choices 426
17.1.3.4.3 Weaknesses & competitive threats 426
17.1.4 QIAGEN 427
17.1.4.1 Business overview 427
17.1.4.2 Products/Services/Solutions offered 428
17.1.4.3 Recent developments 431
17.1.4.3.1 Product launches 431
17.1.4.4 MnM view 432
17.1.4.4.1 Key strengths 432
17.1.4.4.2 Strategic choices 432
17.1.4.4.3 Weaknesses & competitive threats 432
17.1.5 MERCK KGAA 433
17.1.5.1 Business overview 433
17.1.5.2 Products/Services/Solutions offered 434
17.1.5.3 Recent developments 436
17.1.5.3.1 Expansions 436
17.1.5.4 MnM view 436
17.1.5.4.1 Key strengths 436
17.1.5.4.2 Strategic choices 436
17.1.5.4.3 Weaknesses & competitive threats 436
17.1.6 AVANTOR, INC. 437
17.1.6.1 Business overview 437
17.1.6.2 Products/Services/Solutions offered 438
17.1.6.3 Recent developments 442
17.1.6.3.1 Deals 442
17.1.6.3.2 Expansions 442
17.1.7 CRYOPORT 443
17.1.7.1 Business overview 443
17.1.7.2 Products/Services/Solutions offered 444
17.1.7.3 Recent developments 446
17.1.7.3.1 Product launches 446
17.1.7.3.2 Deals 446
17.1.7.3.3 Expansions 448
?
17.1.8 TECAN TRADING AG 449
17.1.8.1 Business overview 449
17.1.8.2 Products/Services/Solutions offered 450
17.1.8.3 Recent developments 451
17.1.8.3.1 Product launches 451
17.1.9 AZENTA US INC. 453
17.1.9.1 Business overview 453
17.1.9.2 Products/Services/Solutions offered 454
17.1.9.3 Recent developments 455
17.1.9.3.1 Product launches 455
17.1.9.3.2 Deals 456
17.1.9.3.3 Expansions 456
17.1.10 GREINER AG 457
17.1.10.1 Business overview 457
17.1.10.2 Products/Services/Solutions offered 458
17.1.10.3 Recent developments 459
17.1.10.3.1 Product launches 459
17.1.10.3.2 Expansions 460
17.1.11 AGILENT TECHNOLOGIES, INC. 461
17.1.11.1 Business overview 461
17.1.11.2 Products/Services/Solutions offered 462
17.1.12 LABCORP 463
17.1.12.1 Business overview 463
17.1.12.2 Products/Services/Solutions offered 464
17.1.12.3 Recent developments 465
17.1.12.3.1 Deals 465
17.1.13 EUROFINS SCIENTIFIC 466
17.1.13.1 Business overview 466
17.1.13.2 Products/Services/Solutions offered 467
17.2 OTHER PLAYERS 468
17.2.1 HAIER BIOMEDICAL 468
17.2.2 HAMILTON COMPANY 469
17.2.3 AMSBIO 471
17.2.4 BAY BIOSCIENCES 472
17.2.5 BIOKRYO 473
17.2.6 SPT LABTECH LTD. 474
17.2.7 ASKION GMBH 475
17.2.8 CTIBIOTECH 476
17.2.9 CURELINE 477
17.2.10 FIRALIS MOLECULAR PRECISION 478
17.2.11 SOPACHEM 479
17.2.12 FROILABO 480
17.2.13 BIOIVT 481
18 APPENDIX 482
18.1 DISCUSSION GUIDE 482
18.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL 487
18.3 CUSTOMIZATION OPTIONS 489
18.4 RELATED REPORTS 490
18.5 AUTHOR DETAILS 491
TABLE 1 BIOBANKING MARKET: INCLUSIONS & EXCLUSIONS 48
TABLE 2 IMPACT ANALYSIS OF SUPPLY- AND DEMAND-SIDE FACTORS 61
TABLE 3 BIOBANKING MARKET: RISK ANALYSIS 65
TABLE 4 BIOBANKING MARKET: IMPACT ANALYSIS 76
TABLE 5 AVERAGE SELLING PRICE OF BIOBANKING PRODUCTS, BY KEY PLAYER, 2024 82
TABLE 6 INDICATIVE PRICING OF BIOBANKING SERVICES, BY SERVICE TYPE, 2024 83
TABLE 7 INDICATIVE PRICING TREND FOR BIOBANKING PRODUCTS, BY REGION, 2022?2024 (USD) 83
TABLE 8 BIOBANKING MARKET: ROLE IN ECOSYSTEM 86
TABLE 9 DETAILED ANALYSIS OF KEY PATENTS IN BIOBANKING MARKET, 2022-2025 90
TABLE 10 BIOBANKING MARKET: LIST OF KEY CONFERENCES & EVENTS, JANUARY 2025?DECEMBER 2026 93
TABLE 11 BIOBANKING MARKET: REGULATORY BODIES, GOVERNMENT
AGENCIES, AND OTHER ORGANIZATIONS 95
TABLE 12 IMPORT DATA FOR HS CODE 8418, BY COUNTRY, 2020-2024 (USD THOUSANDS) 96
TABLE 13 EXPORT DATA FOR HS CODE 8418, BY COUNTRY, 2020-2024 (USD THOUSANDS) 97
TABLE 14 BIOBANKING MARKET: PORTER'S FIVE FORCES 97
TABLE 15 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY OFFERING 100
TABLE 16 BUYING CRITERIA FOR BIOBANKING PRODUCTS MARKET, BY END USER 101
TABLE 17 BUYING CRITERIA FOR BIOBANKING SERVICES, BY END USER 103
TABLE 18 US ADJUSTED RECIPROCAL TARIFF RATES 107
TABLE 19 BIOBANKING MARKET, BY OFFERING, 2023-2030 (USD MILLION) 112
TABLE 20 BIOBANKING PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION) 112
TABLE 21 BIOBANKING PRODUCTS MARKET FOR EQUIPMENT, BY TYPE,
2023-2030 (USD MILLION) 112
TABLE 22 BIOBANKING PRODUCTS MARKET, BY REGION, 2023-2030 (USD MILLION) 113
TABLE 23 NORTH AMERICA: BIOBANKING PRODUCTS MARKET, BY COUNTRY,
2023-2030 (USD MILLION) 114
TABLE 24 EUROPE: BIOBANKING PRODUCTS MARKET, BY COUNTRY,
2023-2030 (USD MILLION) 114
TABLE 25 ASIA PACIFIC: BIOBANKING PRODUCTS MARKET, BY COUNTRY,
2023-2030 (USD MILLION) 114
TABLE 26 LATIN AMERICA: BIOBANKING PRODUCTS MARKET, BY COUNTRY,
2023-2030 (USD MILLION) 115
TABLE 27 MIDDLE EAST: BIOBANKING PRODUCTS MARKET, BY REGION,
2023-2030 (USD MILLION) 115
TABLE 28 GCC COUNTRIES: BIOBANKING PRODUCTS MARKET, BY COUNTRY,
2023-2030 (USD MILLION) 115
TABLE 29 BIOBANKING PRODUCTS MARKET FOR EQUIPMENT, BY REGION,
2023-2030 (USD MILLION) 116
TABLE 30 NORTH AMERICA: BIOBANKING PRODUCTS MARKET FOR EQUIPMENT,
BY COUNTRY, 2023-2030 (USD MILLION) 116
TABLE 31 EUROPE: BIOBANKING PRODUCTS MARKET FOR EQUIPMENT, BY COUNTRY,
2023-2030 (USD MILLION) 117
TABLE 32 ASIA PACIFIC: BIOBANKING PRODUCTS MARKET FOR EQUIPMENT, BY COUNTRY, 2023-2030 (USD MILLION) 117
TABLE 33 LATIN AMERICA: BIOBANKING PRODUCTS MARKET FOR EQUIPMENT, BY COUNTRY, 2023-2030 (USD MILLION) 117
TABLE 34 MIDDLE EAST: BIOBANKING PRODUCTS MARKET FOR EQUIPMENT, BY REGION, 2023-2030 (USD MILLION) 118
TABLE 35 GCC COUNTRIES: BIOBANKING PRODUCTS MARKET FOR EQUIPMENT,
BY COUNTRY, 2023-2030 (USD MILLION) 118
TABLE 36 BIOBANKING MARKET FOR FREEZERS & REFRIGERATORS, BY REGION,
2023-2030 (USD MILLION) 119
TABLE 37 NORTH AMERICA: BIOBANKING MARKET FOR FREEZERS & REFRIGERATORS,
BY COUNTRY, 2023-2030 (USD MILLION) 119
TABLE 38 EUROPE: BIOBANKING MARKET FOR FREEZERS & REFRIGERATORS,
BY COUNTRY, 2023-2030 (USD MILLION) 119
TABLE 39 ASIA PACIFIC: BIOBANKING MARKET FOR FREEZERS & REFRIGERATORS,
BY COUNTRY, 2023-2030 (USD MILLION) 120
TABLE 40 LATIN AMERICA: BIOBANKING MARKET FOR FREEZERS & REFRIGERATORS,
BY COUNTRY, 2023-2030 (USD MILLION) 120
TABLE 41 MIDDLE EAST: BIOBANKING MARKET FOR FREEZERS & REFRIGERATORS,
BY REGION, 2023-2030 (USD MILLION) 120
TABLE 42 GCC COUNTRIES: BIOBANKING MARKET FOR FREEZERS & REFRIGERATORS,
BY COUNTRY, 2023-2030 (USD MILLION) 121
TABLE 43 BIOBANKING MARKET FOR CRYOGENIC STORAGE SYSTEMS, BY REGION,
2023-2030 (USD MILLION) 121
TABLE 44 NORTH AMERICA: BIOBANKING MARKET FOR CRYOGENIC STORAGE SYSTEMS,
BY COUNTRY, 2023-2030 (USD MILLION) 122
TABLE 45 EUROPE: BIOBANKING MARKET FOR CRYOGENIC STORAGE SYSTEMS,
BY COUNTRY, 2023-2030 (USD MILLION) 122
TABLE 46 ASIA PACIFIC: BIOBANKING MARKET FOR CRYOGENIC STORAGE SYSTEMS,
BY COUNTRY, 2023-2030 (USD MILLION) 122
TABLE 47 LATIN AMERICA: BIOBANKING MARKET FOR CRYOGENIC STORAGE SYSTEMS,
BY COUNTRY, 2023-2030 (USD MILLION) 123
TABLE 48 MIDDLE EAST: BIOBANKING MARKET FOR CRYOGENIC STORAGE SYSTEMS,
BY REGION, 2023-2030 (USD MILLION) 123
TABLE 49 GCC COUNTRIES: BIOBANKING MARKET FOR CRYOGENIC STORAGE SYSTEMS,
BY COUNTRY, 2023-2030 (USD MILLION) 123
TABLE 50 BIOBANKING MARKET FOR ALARM & MONITORING SYSTEMS, BY REGION,
2023-2030 (USD MILLION) 124
TABLE 51 NORTH AMERICA: BIOBANKING MARKET FOR ALARM & MONITORING SYSTEMS,
BY COUNTRY, 2023-2030 (USD MILLION) 124
TABLE 52 EUROPE: BIOBANKING MARKET FOR ALARM & MONITORING SYSTEMS,
BY COUNTRY, 2023-2030 (USD MILLION) 125
TABLE 53 ASIA PACIFIC: BIOBANKING MARKET FOR ALARM & MONITORING SYSTEMS,
BY COUNTRY, 2023-2030 (USD MILLION) 125
TABLE 54 LATIN AMERICA: BIOBANKING MARKET FOR ALARM & MONITORING SYSTEMS,
BY COUNTRY, 2023-2030 (USD MILLION) 125
TABLE 55 MIDDLE EAST: BIOBANKING MARKET FOR ALARM & MONITORING SYSTEMS,
BY REGION, 2023-2030 (USD MILLION) 126
TABLE 56 GCC COUNTRIES: BIOBANKING MARKET FOR ALARM & MONITORING SYSTEMS,
BY COUNTRY, 2023-2030 (USD MILLION) 126
TABLE 57 BIOBANKING MARKET FOR THAWING EQUIPMENT, BY REGION,
2023-2030 (USD MILLION) 127
TABLE 58 NORTH AMERICA: BIOBANKING MARKET FOR THAWING EQUIPMENT, BY COUNTRY, 2023-2030 (USD MILLION) 127
TABLE 59 EUROPE: BIOBANKING MARKET FOR THAWING EQUIPMENT, BY COUNTRY,
2023-2030 (USD MILLION) 127
TABLE 60 ASIA PACIFIC: BIOBANKING MARKET FOR THAWING EQUIPMENT, BY COUNTRY, 2023-2030 (USD MILLION) 128
TABLE 61 LATIN AMERICA: BIOBANKING MARKET FOR THAWING EQUIPMENT, BY COUNTRY, 2023-2030 (USD MILLION) 128
TABLE 62 MIDDLE EAST: BIOBANKING MARKET FOR THAWING EQUIPMENT, BY REGION, 2023-2030 (USD MILLION) 128
TABLE 63 GCC COUNTRIES: BIOBANKING MARKET FOR THAWING EQUIPMENT, BY COUNTRY, 2023-2030 (USD MILLION) 129
TABLE 64 BIOBANKING MARKET FOR TEMPERATURE & HUMIDITY CONTROL SYSTEMS,
BY REGION, 2023-2030 (USD MILLION) 129
TABLE 65 NORTH AMERICA: BIOBANKING MARKET FOR TEMPERATURE & HUMIDITY CONTROL SYSTEMS, BY COUNTRY, 2023-2030 (USD MILLION) 130
TABLE 66 EUROPE: BIOBANKING MARKET FOR TEMPERATURE & HUMIDITY CONTROL SYSTEMS, BY COUNTRY, 2023-2030 (USD MILLION) 130
TABLE 67 ASIA PACIFIC: BIOBANKING MARKET FOR TEMPERATURE & HUMIDITY CONTROL SYSTEMS, BY COUNTRY, 2023-2030 (USD MILLION) 130
TABLE 68 LATIN AMERICA: BIOBANKING MARKET FOR TEMPERATURE & HUMIDITY CONTROL SYSTEMS, BY COUNTRY, 2023-2030 (USD MILLION) 131
TABLE 69 MIDDLE EAST: BIOBANKING MARKET FOR TEMPERATURE & HUMIDITY CONTROL SYSTEMS, BY REGION, 2023-2030 (USD MILLION) 131
TABLE 70 GCC COUNTRIES: BIOBANKING MARKET FOR TEMPERATURE & HUMIDITY CONTROL SYSTEMS, BY COUNTRY, 2023-2030 (USD MILLION) 131
TABLE 71 BIOBANKING MARKET FOR OTHER EQUIPMENT & ACCESSORIES, BY REGION, 2023-2030 (USD MILLION) 132
TABLE 72 NORTH AMERICA: BIOBANKING MARKET FOR OTHER EQUIPMENT & ACCESSORIES, BY COUNTRY, 2023-2030 (USD MILLION) 132
TABLE 73 EUROPE: BIOBANKING MARKET FOR OTHER EQUIPMENT & ACCESSORIES,
BY COUNTRY, 2023-2030 (USD MILLION) 133
TABLE 74 ASIA PACIFIC: BIOBANKING MARKET FOR OTHER EQUIPMENT & ACCESSORIES,
BY COUNTRY, 2023-2030 (USD MILLION) 133
TABLE 75 LATIN AMERICA: BIOBANKING MARKET FOR OTHER EQUIPMENT & ACCESSORIES, BY COUNTRY, 2023-2030 (USD MILLION) 133
TABLE 76 MIDDLE EAST: BIOBANKING MARKET FOR OTHER EQUIPMENT & ACCESSORIES,
BY REGION, 2023-2030 (USD MILLION) 134
TABLE 77 GCC COUNTRIES: BIOBANKING MARKET FOR OTHER EQUIPMENT & ACCESSORIES, BY COUNTRY, 2023-2030 (USD MILLION) 134
TABLE 78 BIOBANKING PRODUCTS MARKET FOR CONSUMABLES, BY REGION,
2023-2030 (USD MILLION) 135
TABLE 79 NORTH AMERICA: BIOBANKING PRODUCTS MARKET FOR CONSUMABLES,
BY COUNTRY, 2023-2030 (USD MILLION) 135
TABLE 80 EUROPE: BIOBANKING PRODUCTS MARKET FOR CONSUMABLES, BY COUNTRY, 2023-2030 (USD MILLION) 136
TABLE 81 ASIA PACIFIC: BIOBANKING PRODUCTS MARKET FOR CONSUMABLES,
BY COUNTRY, 2023-2030 (USD MILLION) 136
TABLE 82 LATIN AMERICA: BIOBANKING PRODUCTS MARKET FOR CONSUMABLES,
BY COUNTRY, 2023-2030 (USD MILLION) 136
TABLE 83 MIDDLE EAST: BIOBANKING PRODUCTS MARKET FOR CONSUMABLES, BY REGION, 2023-2030 (USD MILLION) 137
TABLE 84 GCC COUNTRIES: BIOBANKING PRODUCTS MARKET FOR CONSUMABLES,
BY COUNTRY, 2023-2030 (USD MILLION) 137
TABLE 85 BIOBANKING SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION) 138
TABLE 86 NORTH AMERICA: BIOBANKING SERVICES MARKET, BY COUNTRY,
2023-2030 (USD MILLION) 138
TABLE 87 EUROPE: BIOBANKING SERVICES MARKET, BY COUNTRY,
2023-2030 (USD MILLION) 139
TABLE 88 ASIA PACIFIC: BIOBANKING SERVICES MARKET, BY COUNTRY,
2023-2030 (USD MILLION) 139
TABLE 89 LATIN AMERICA: BIOBANKING SERVICES MARKET, BY COUNTRY,
2023-2030 (USD MILLION) 139
TABLE 90 MIDDLE EAST: BIOBANKING SERVICES MARKET, BY REGION,
2023-2030 (USD MILLION) 140
TABLE 91 GCC COUNTRIES: BIOBANKING SERVICES MARKET, BY COUNTRY,
2023-2030 (USD MILLION) 140
TABLE 92 BIOBANKING SOFTWARE MARKET, BY REGION, 2023-2030 (USD MILLION) 141
TABLE 93 NORTH AMERICA: BIOBANKING SOFTWARE MARKET, BY COUNTRY,
2023-2030 (USD MILLION) 141
TABLE 94 EUROPE: BIOBANKING SOFTWARE MARKET, BY COUNTRY,
2023-2030 (USD MILLION) 142
TABLE 95 ASIA PACIFIC: BIOBANKING SOFTWARE MARKET, BY COUNTRY,
2023-2030 (USD MILLION) 142
TABLE 96 LATIN AMERICA: BIOBANKING SOFTWARE MARKET, BY COUNTRY,
2023-2030 (USD MILLION) 142
TABLE 97 MIDDLE EAST: BIOBANKING SOFTWARE MARKET, BY REGION,
2023-2030 (USD MILLION) 143
TABLE 98 GCC COUNTRIES: BIOBANKING SOFTWARE MARKET, BY COUNTRY,
2023-2030 (USD MILLION) 143
TABLE 99 BIOBANKING EQUIPMENT MARKET, BY OPERATION TYPE,
2023-2030 (USD MILLION) 145
TABLE 100 BIOBANKING EQUIPMENT MARKET FOR MANUAL OPERATIONS, BY REGION,
2023-2030 (USD MILLION) 146
TABLE 101 NORTH AMERICA: BIOBANKING EQUIPMENT MARKET FOR MANUAL OPERATIONS, BY COUNTRY, 2023-2030 (USD MILLION) 146
TABLE 102 EUROPE: BIOBANKING EQUIPMENT MARKET FOR MANUAL OPERATIONS,
BY COUNTRY, 2023-2030 (USD MILLION) 146
TABLE 103 ASIA PACIFIC: BIOBANKING EQUIPMENT MARKET FOR MANUAL OPERATIONS,
BY COUNTRY, 2023-2030 (USD MILLION) 147
TABLE 104 LATIN AMERICA: BIOBANKING EQUIPMENT MARKET FOR MANUAL OPERATIONS,
BY COUNTRY, 2023-2030 (USD MILLION) 147
TABLE 105 MIDDLE EAST: BIOBANKING EQUIPMENT MARKET FOR MANUAL OPERATIONS,
BY REGION, 2023-2030 (USD MILLION) 147
TABLE 106 GCC COUNTRIES: BIOBANKING EQUIPMENT MARKET FOR MANUAL OPERATIONS, BY REGION, 2023-2030 (USD MILLION) 148
TABLE 107 BIOBANKING EQUIPMENT MARKET FOR AUTOMATED OPERATIONS, BY REGION, 2023-2030 (USD MILLION) 149
TABLE 108 NORTH AMERICA: BIOBANKING EQUIPMENT MARKET FOR AUTOMATED OPERATIONS, BY COUNTRY, 2023-2030 (USD MILLION) 149
TABLE 109 EUROPE: BIOBANKING EQUIPMENT MARKET FOR AUTOMATED OPERATIONS,
BY COUNTRY, 2023-2030 (USD MILLION) 149
TABLE 110 ASIA PACIFIC: BIOBANKING EQUIPMENT MARKET FOR AUTOMATED OPERATIONS, BY COUNTRY, 2023-2030 (USD MILLION) 150
TABLE 111 LATIN AMERICA: BIOBANKING EQUIPMENT MARKET FOR AUTOMATED OPERATIONS, BY COUNTRY, 2023-2030 (USD MILLION) 150
TABLE 112 MIDDLE EAST: BIOBANKING EQUIPMENT MARKET FOR AUTOMATED OPERATIONS, BY REGION, 2023-2030 (USD MILLION) 150
TABLE 113 GCC COUNTRIES: BIOBANKING EQUIPMENT MARKET FOR AUTOMATED OPERATIONS, BY COUNTRY, 2023-2030 (USD MILLION) 151
TABLE 114 BIOBANKING PRODUCTS MARKET, BY WORKFLOW, 2023-2030 (USD MILLION) 153
TABLE 115 BIOBANKING PRODUCTS MARKET FOR SAMPLE COLLECTION & STORAGE,
BY REGION, 2023-2030 (USD MILLION) 154
TABLE 116 NORTH AMERICA: BIOBANKING PRODUCTS MARKET FOR SAMPLE COLLECTION & STORAGE, BY COUNTRY, 2023-2030 (USD MILLION) 154
TABLE 117 EUROPE: BIOBANKING PRODUCTS MARKET FOR SAMPLE COLLECTION & STORAGE, BY COUNTRY, 2023-2030 (USD MILLION) 154
TABLE 118 ASIA PACIFIC: BIOBANKING PRODUCTS MARKET FOR SAMPLE COLLECTION & STORAGE, BY COUNTRY, 2023-2030 (USD MILLION) 155
TABLE 119 LATIN AMERICA: BIOBANKING PRODUCTS MARKET FOR SAMPLE COLLECTION & STORAGE, BY COUNTRY, 2023-2030 (USD MILLION) 155
TABLE 120 MIDDLE EAST: BIOBANKING PRODUCTS MARKET FOR SAMPLE COLLECTION & STORAGE, BY REGION, 2023-2030 (USD MILLION) 155
TABLE 121 GCC COUNTRIES: BIOBANKING PRODUCTS MARKET FOR SAMPLE COLLECTION AND STORAGE, BY REGION, 2023-2030 (USD MILLION) 156
TABLE 122 BIOBANKING PRODUCTS MARKET FOR SAMPLE PROCESSING, BY REGION,
2023-2030 (USD MILLION) 157
TABLE 123 NORTH AMERICA: BIOBANKING PRODUCTS MARKET FOR SAMPLE PROCESSING, BY COUNTRY, 2023-2030 (USD MILLION) 157
TABLE 124 EUROPE: BIOBANKING PRODUCTS MARKET FOR SAMPLE PROCESSING,
BY COUNTRY, 2023-2030 (USD MILLION) 157
TABLE 125 ASIA PACIFIC: BIOBANKING PRODUCTS MARKET FOR SAMPLE PROCESSING,
BY COUNTRY, 2023-2030 (USD MILLION) 158
TABLE 126 LATIN AMERICA: BIOBANKING PRODUCTS MARKET FOR SAMPLE PROCESSING,
BY COUNTRY, 2023-2030 (USD MILLION) 158
TABLE 127 MIDDLE EAST: BIOBANKING PRODUCTS MARKET FOR SAMPLE PROCESSING,
BY REGION, 2023-2030 (USD MILLION) 158
TABLE 128 GCC COUNTRIES: BIOBANKING PRODUCTS MARKET FOR SAMPLE PROCESSING,
BY COUNTRY, 2023-2030 (USD MILLION) 159
TABLE 129 BIOBANKING PRODUCTS MARKET FOR SAMPLE ANALYSIS, BY REGION,
2023-2030 (USD MILLION) 160
TABLE 130 NORTH AMERICA: BIOBANKING MARKET FOR SAMPLE ANALYSIS, BY COUNTRY, 2023-2030 (USD MILLION) 160
TABLE 131 EUROPE: BIOBANKING MARKET FOR SAMPLE ANALYSIS, BY COUNTRY,
2023-2030 (USD MILLION) 160
TABLE 132 ASIA PACIFIC: BIOBANKING MARKET FOR SAMPLE ANALYSIS, BY COUNTRY,
2023-2030 (USD MILLION) 161
TABLE 133 LATIN AMERICA: BIOBANKING MARKET FOR SAMPLE ANALYSIS, BY COUNTRY, 2023-2030 (USD MILLION) 161
TABLE 134 MIDDLE EAST: BIOBANKING MARKET FOR SAMPLE ANALYSIS, BY REGION,
2023-2030 (USD MILLION) 161
TABLE 135 GCC COUNTRIES: BIOBANKING MARKET FOR SAMPLE ANALYSIS, BY COUNTRY, 2023-2030 (USD MILLION) 162
TABLE 136 BIOBANKING PRODUCTS MARKET FOR TRANSPORT & LOGISTICS, BY REGION, 2023-2030 (USD MILLION) 163
TABLE 137 NORTH AMERICA: BIOBANKING MARKET FOR TRANSPORT & LOGISTICS,
BY COUNTRY, 2023-2030 (USD MILLION) 163
TABLE 138 EUROPE: BIOBANKING MARKET FOR TRANSPORT & LOGISTICS, BY COUNTRY, 2023-2030 (USD MILLION) 163
TABLE 139 ASIA PACIFIC: BIOBANKING MARKET FOR TRANSPORT & LOGISTICS, BY COUNTRY, 2023-2030 (USD MILLION) 164
TABLE 140 LATIN AMERICA: BIOBANKING MARKET FOR TRANSPORT & LOGISTICS,
BY COUNTRY, 2023-2030 (USD MILLION) 164
TABLE 141 MIDDLE EAST: BIOBANKING MARKET FOR TRANSPORT & LOGISTICS, BY REGION, 2023-2030 (USD MILLION) 164
TABLE 142 GCC COUNTRIES: BIOBANKING MARKET FOR TRANSPORT & LOGISTICS,
BY COUNTRY, 2023-2030 (USD MILLION) 165
TABLE 143 BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE, 2023-2030 (USD MILLION) 167
TABLE 144 BIOBANKING PRODUCTS MARKET FOR BLOOD PRODUCTS, BY REGION,
2023-2030 (USD MILLION) 168
TABLE 145 NORTH AMERICA: BIOBANKING PRODUCTS MARKET FOR BLOOD PRODUCTS,
BY REGION, 2023-2030 (USD MILLION) 168
TABLE 146 EUROPE: BIOBANKING PRODUCTS MARKET FOR BLOOD PRODUCTS, BY COUNTRY, 2023-2030 (USD MILLION) 168
TABLE 147 ASIA PACIFIC: BIOBANKING PRODUCTS MARKET FOR BLOOD PRODUCTS,
BY COUNTRY, 2023-2030 (USD MILLION) 169
TABLE 148 LATIN AMERICA: BIOBANKING PRODUCTS MARKET FOR BLOOD PRODUCTS,
BY COUNTRY, 2023-2030 (USD MILLION) 169
TABLE 149 MIDDLE EAST: BIOBANKING PRODUCTS MARKET FOR BLOOD PRODUCTS,
BY REGION, 2023-2030 (USD MILLION) 169
TABLE 150 GCC COUNTRIES: BIOBANKING PRODUCTS MARKET FOR BLOOD PRODUCTS,
BY COUNTRY, 2023-2030 (USD MILLION) 170
TABLE 151 BIOBANKING PRODUCTS MARKET FOR SOLID TISSUES & ORGANS, BY REGION, 2023-2030 (USD MILLION) 170
TABLE 152 NORTH AMERICA: BIOBANKING PRODUCTS MARKET FOR SOLID TISSUES & ORGANS, BY COUNTRY, 2023-2030 (USD MILLION) 171
TABLE 153 EUROPE: BIOBANKING PRODUCTS MARKET FOR SOLID TISSUES & ORGANS,
BY COUNTRY, 2023-2030 (USD MILLION) 171
TABLE 154 ASIA PACIFIC: BIOBANKING PRODUCTS MARKET FOR SOLID TISSUES & ORGANS, BY COUNTRY, 2023-2030 (USD MILLION) 171
TABLE 155 LATIN AMERICA: BIOBANKING PRODUCTS MARKET FOR SOLID TISSUES & ORGANS, BY COUNTRY, 2023-2030 (USD MILLION) 172
TABLE 156 MIDDLE EAST: BIOBANKING PRODUCTS MARKET FOR SOLID TISSUES & ORGANS, BY REGION, 2023-2030 (USD MILLION) 172
TABLE 157 GCC COUNTRIES: BIOBANKING PRODUCTS MARKET FOR SOLID TISSUES & ORGANS, BY COUNTRY, 2023-2030 (USD MILLION) 172
TABLE 158 BIOBANKING PRODUCTS MARKET FOR STEM CELLS & CELL LINES, BY REGION, 2023-2030 (USD MILLION) 173
TABLE 159 NORTH AMERICA: BIOBANKING PRODUCTS MARKET FOR STEM CELLS & CELL LINES, BY COUNTRY, 2023-2030 (USD MILLION) 173
TABLE 160 EUROPE: BIOBANKING PRODUCTS MARKET FOR STEM CELLS & CELL LINES,
BY COUNTRY, 2023-2030 (USD MILLION) 174
TABLE 161 ASIA PACIFIC: BIOBANKING PRODUCTS MARKET FOR STEM CELLS & CELL LINES, BY COUNTRY, 2023-2030 (USD MILLION) 174
TABLE 162 LATIN AMERICA: BIOBANKING PRODUCTS MARKET FOR STEM CELLS &
CELL LINES, BY COUNTRY, 2023-2030 (USD MILLION) 174
TABLE 163 MIDDLE EAST: BIOBANKING PRODUCTS MARKET FOR STEM CELLS &
CELL LINES, BY REGION, 2023-2030 (USD MILLION) 175
TABLE 164 GCC COUNTRIES: BIOBANKING PRODUCTS MARKET FOR STEM CELLS &
CELL LINES, BY COUNTRY, 2023-2030 (USD MILLION) 175
TABLE 165 BIOBANKING PRODUCTS MARKET FOR BIOLOGICAL FLUIDS, BY REGION,
2023-2030 (USD MILLION) 176
TABLE 166 NORTH AMERICA: BIOBANKING PRODUCTS MARKET FOR BIOLOGICAL FLUIDS,
BY COUNTRY, 2023-2030 (USD MILLION) 176
TABLE 167 EUROPE: BIOBANKING PRODUCTS MARKET FOR BIOLOGICAL FLUIDS,
BY COUNTRY, 2023-2030 (USD MILLION) 176
TABLE 168 ASIA PACIFIC: BIOBANKING PRODUCTS MARKET FOR BIOLOGICAL FLUIDS,
BY COUNTRY, 2023-2030 (USD MILLION) 177
TABLE 169 LATIN AMERICA: BIOBANKING PRODUCTS MARKET FOR BIOLOGICAL FLUIDS,
BY COUNTRY, 2023-2030 (USD MILLION) 177
TABLE 170 MIDDLE EAST: BIOBANKING PRODUCTS MARKET FOR BIOLOGICAL FLUIDS,
BY REGION, 2023-2030 (USD MILLION) 177
TABLE 171 GCC COUNTRIES: BIOBANKING PRODUCTS MARKET FOR BIOLOGICAL FLUIDS,
BY COUNTRY, 2023-2030 (USD MILLION) 178
TABLE 172 BIOBANKING PRODUCTS MARKET FOR NUCLEIC ACIDS, BY REGION,
2023-2030 (USD MILLION) 178
TABLE 173 NORTH AMERICA: BIOBANKING PRODUCTS MARKET FOR NUCLEIC ACIDS,
BY COUNTRY, 2023-2030 (USD MILLION) 179
TABLE 174 EUROPE: BIOBANKING PRODUCTS MARKET FOR NUCLEIC ACIDS, BY COUNTRY, 2023-2030 (USD MILLION) 179
TABLE 175 ASIA PACIFIC: BIOBANKING PRODUCTS MARKET FOR NUCLEIC ACIDS,
BY COUNTRY, 2023-2030 (USD MILLION) 179
TABLE 176 LATIN AMERICA: BIOBANKING PRODUCTS MARKET FOR NUCLEIC ACIDS,
BY COUNTRY, 2023-2030 (USD MILLION) 180
TABLE 177 MIDDLE EAST: BIOBANKING PRODUCTS MARKET FOR NUCLEIC ACIDS,
BY REGION, 2023-2030 (USD MILLION) 180
TABLE 178 GCC COUNTRIES: BIOBANKING PRODUCTS MARKET FOR NUCLEIC ACIDS,
BY COUNTRY, 2023-2030 (USD MILLION) 180
TABLE 179 BIOBANKING PRODUCTS MARKET FOR HUMAN WASTE PRODUCTS, BY REGION, 2023-2030 (USD MILLION) 181
TABLE 180 NORTH AMERICA: BIOBANKING PRODUCTS MARKET FOR HUMAN WASTE PRODUCTS, BY COUNTRY, 2023-2030 (USD MILLION) 181
TABLE 181 EUROPE: BIOBANKING PRODUCTS MARKET FOR HUMAN WASTE PRODUCTS,
BY COUNTRY, 2023-2030 (USD MILLION) 182
TABLE 182 ASIA PACIFIC: BIOBANKING PRODUCTS MARKET FOR HUMAN WASTE PRODUCTS, BY COUNTRY, 2023-2030 (USD MILLION) 182
TABLE 183 LATIN AMERICA: BIOBANKING PRODUCTS MARKET FOR HUMAN WASTE PRODUCTS, BY COUNTRY, 2023-2030 (USD MILLION) 182
TABLE 184 MIDDLE EAST: BIOBANKING PRODUCTS MARKET FOR HUMAN WASTE PRODUCTS, BY REGION, 2023-2030 (USD MILLION) 183
TABLE 185 GCC COUNTRIES: BIOBANKING PRODUCTS MARKET FOR HUMAN WASTE PRODUCTS, BY COUNTRY, 2023-2030 (USD MILLION) 183
TABLE 186 BIOBANKING PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION) 185
TABLE 187 BIOBANKING PRODUCTS MARKET FOR BIOBANKS, BY REGION,
2023-2030 (USD MILLION) 186
TABLE 188 NORTH AMERICA: BIOBANKING PRODUCTS MARKET FOR BIOBANKS, BY COUNTRY, 2023-2030 (USD MILLION) 186
TABLE 189 EUROPE: BIOBANKING PRODUCTS MARKET FOR BIOBANKS, BY COUNTRY,
2023-2030 (USD MILLION) 186
TABLE 190 ASIA PACIFIC: BIOBANKING PRODUCTS MARKET FOR BIOBANKS, BY COUNTRY, 2023-2030 (USD MILLION) 187
TABLE 191 LATIN AMERICA: BIOBANKING PRODUCTS MARKET FOR BIOBANKS, BY COUNTRY, 2023-2030 (USD MILLION) 187
TABLE 192 MIDDLE EAST: BIOBANKING PRODUCTS MARKET FOR BIOBANKS, BY REGION, 2023-2030 (USD MILLION) 187
TABLE 193 GCC COUNTRIES: BIOBANKING PRODUCTS MARKET FOR BIOBANKS, BY COUNTRY, 2023-2030 (USD MILLION) 188
TABLE 194 BIOBANKING PRODUCTS MARKET FOR CROS, BY REGION,
2023-2030 (USD MILLION) 189
TABLE 195 NORTH AMERICA: BIOBANKING PRODUCTS MARKET FOR CROS, BY COUNTRY, 2023-2030 (USD MILLION) 189
TABLE 196 EUROPE: BIOBANKING PRODUCTS MARKET FOR CROS, BY COUNTRY,
2023-2030 (USD MILLION) 189
TABLE 197 ASIA PACIFIC: BIOBANKING PRODUCTS MARKET FOR CROS, BY COUNTRY,
2023-2030 (USD MILLION) 190
TABLE 198 LATIN AMERICA: BIOBANKING PRODUCTS MARKET FOR CROS, BY COUNTRY, 2023-2030 (USD MILLION) 190
TABLE 199 MIDDLE EAST: BIOBANKING PRODUCTS MARKET FOR CROS, BY REGION,
2023-2030 (USD MILLION) 190
TABLE 200 GCC COUNTRIES: BIOBANKING PRODUCTS MARKET FOR CROS, BY COUNTRY, 2023-2030 (USD MILLION) 191
TABLE 201 BIOBANKING SERVICES MARKET, BY OWNERSHIP, 2023-2030 (USD MILLION) 193
TABLE 202 BIOBANKING SERVICES MARKET FOR PRIVATE/COMMERCIAL BIOBANKS,
BY REGION, 2023-2030 (USD MILLION) 194
TABLE 203 NORTH AMERICA: BIOBANKING SERVICES MARKET FOR PRIVATE/COMMERCIAL BIOBANKS, BY COUNTRY, 2023-2030 (USD MILLION) 194
TABLE 204 EUROPE: BIOBANKING SERVICES MARKET FOR PRIVATE/COMMERCIAL BIOBANKS, BY COUNTRY, 2023-2030 (USD MILLION) 194
TABLE 205 ASIA PACIFIC: BIOBANKING SERVICES MARKET FOR PRIVATE/COMMERCIAL BIOBANKS, BY COUNTRY, 2023-2030 (USD MILLION) 195
TABLE 206 LATIN AMERICA: BIOBANKING SERVICES MARKET FOR PRIVATE/COMMERCIAL BIOBANKS, BY COUNTRY, 2023-2030 (USD MILLION) 195
TABLE 207 MIDDLE EAST: BIOBANKING SERVICES MARKET FOR PRIVATE/COMMERCIAL BIOBANKS, BY REGION, 2023-2030 (USD MILLION) 195
TABLE 208 GCC COUNTRIES: BIOBANKING SERVICES MARKET FOR PRIVATE/COMMERCIAL BIOBANKS, BY COUNTRY, 2023-2030 (USD MILLION) 196
TABLE 209 BIOBANKING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTION BIOBANKS, BY REGION, 2023-2030 (USD MILLION) 197
TABLE 210 NORTH AMERICA: BIOBANKING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTION BIOBANKS, BY COUNTRY, 2023-2030 (USD MILLION) 197
TABLE 211 EUROPE: BIOBANKING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTION BIOBANKS, BY COUNTRY, 2023-2030 (USD MILLION) 197
TABLE 212 ASIA PACIFIC: BIOBANKING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTION BIOBANKS, BY COUNTRY, 2023-2030 (USD MILLION) 198
TABLE 213 LATIN AMERICA: BIOBANKING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTION BIOBANKS, BY COUNTRY, 2023-2030 (USD MILLION) 198
TABLE 214 MIDDLE EAST: BIOBANKING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTION BIOBANKS, BY REGION, 2023-2030 (USD MILLION) 198
TABLE 215 GCC COUNTRIES: BIOBANKING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTION BIOBANKS, BY COUNTRY, 2023-2030 (USD MILLION) 199
TABLE 216 BIOBANKING SERVICES MARKET FOR NATIONAL/REGIONAL AGENCIES, BY REGION, 2023-2030 (USD MILLION) 200
TABLE 217 NORTH AMERICA: BIOBANKING SERVICES MARKET FOR NATIONAL/REGIONAL AGENCIES, BY COUNTRY, 2023-2030 (USD MILLION) 200
TABLE 218 EUROPE: BIOBANKING SERVICES MARKET FOR NATIONAL/REGIONAL AGENCIES, BY COUNTRY, 2023-2030 (USD MILLION) 200
TABLE 219 ASIA PACIFIC: BIOBANKING SERVICES MARKET FOR NATIONAL/REGIONAL AGENCIES, BY COUNTRY, 2023-2030 (USD MILLION) 201
TABLE 220 LATIN AMERICA: BIOBANKING SERVICES MARKET FOR NATIONAL/REGIONAL AGENCIES, BY COUNTRY, 2023-2030 (USD MILLION) 201
TABLE 221 MIDDLE EAST: BIOBANKING SERVICES MARKET FOR NATIONAL/REGIONAL AGENCIES, BY REGION, 2023-2030 (USD MILLION) 201
TABLE 222 GCC COUNTRIES: BIOBANKING SERVICES MARKET FOR NATIONAL/REGIONAL AGENCIES, BY COUNTRY, 2023-2030 (USD MILLION) 202
TABLE 223 BIOBANKING SERVICES MARKET FOR HYBRID/PPP MODELS, BY REGION,
2023-2030 (USD MILLION) 203
TABLE 224 NORTH AMERICA: BIOBANKING SERVICES MARKET FOR HYBRID/PPP MODELS,
BY COUNTRY, 2023-2030 (USD MILLION) 203
TABLE 225 EUROPE: BIOBANKING SERVICES MARKET FOR HYBRID/PPP MODELS,
BY COUNTRY, 2023-2030 (USD MILLION) 203
TABLE 226 ASIA PACIFIC: BIOBANKING SERVICES MARKET FOR HYBRID/PPP MODELS,
BY COUNTRY, 2023-2030 (USD MILLION) 204
TABLE 227 LATIN AMERICA: BIOBANKING SERVICES MARKET FOR HYBRID/PPP MODELS,
BY COUNTRY, 2023-2030 (USD MILLION) 204
TABLE 228 MIDDLE EAST: BIOBANKING SERVICES MARKET FOR HYBRID/PPP BIOBANKS,
BY REGION, 2023-2030 (USD MILLION) 204
TABLE 229 GCC COUNTRIES: BIOBANKING SERVICES MARKET FOR HYBRID/PPP BIOBANKS, BY REGION, 2023-2030 (USD MILLION) 205
TABLE 230 BIOBANKING SERVICES MARKET FOR OTHER OWNERSHIP MODELS, BY REGION, 2023-2030 (USD MILLION) 205
TABLE 231 NORTH AMERICA: BIOBANKING SERVICES MARKET FOR OTHER OWNERSHIP MODELS, BY COUNTRY, 2023-2030 (USD MILLION) 206
TABLE 232 EUROPE: BIOBANKING SERVICES MARKET FOR OTHER OWNERSHIP MODELS,
BY COUNTRY, 2023-2030 (USD MILLION) 206
TABLE 233 ASIA PACIFIC: BIOBANKING SERVICES MARKET FOR OTHER OWNERSHIP MODELS, BY COUNTRY, 2023-2030 (USD MILLION) 206
TABLE 234 LATIN AMERICA: BIOBANKING SERVICES MARKET FOR OTHER OWNERSHIP MODELS, BY COUNTRY, 2023-2030 (USD MILLION) 207
TABLE 235 MIDDLE EAST: BIOBANKING SERVICES MARKET FOR OTHER OWNERSHIP MODELS, BY REGION, 2023-2030 (USD MILLION) 207
TABLE 236 GCC COUNTRIES: BIOBANKING SERVICES MARKET FOR OTHER OWNERSHIP MODELS, BY COUNTRY, 2023-2030 (USD MILLION) 207
TABLE 237 BIOBANKING MARKET, BY APPLICATION, 2023-2030 (USD MILLION) 209
TABLE 238 BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY REGION,
2023-2030 (USD MILLION) 210
TABLE 239 NORTH AMERICA: BIOBANKING MARKET FOR RESEARCH APPLICATIONS,
BY COUNTRY, 2023-2030 (USD MILLION) 210
TABLE 240 EUROPE: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION) 210
TABLE 241 ASIA PACIFIC: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION) 211
TABLE 242 LATIN AMERICA: BIOBANKING MARKET FOR RESEARCH APPLICATIONS,
BY COUNTRY, 2023-2030 (USD MILLION) 211
TABLE 243 MIDDLE EAST: BIOBANKING MARKET FOR RESEARCH APPLICATIONS,
BY REGION, 2023-2030 (USD MILLION) 211
TABLE 244 GCC COUNTRIES: BIOBANKING MARKET FOR RESEARCH APPLICATIONS,
BY COUNTRY, 2023-2030 (USD MILLION) 212
TABLE 245 BIOBANKING APPLICATIONS MARKET FOR LIFE SCIENCE RESEARCH,
BY REGION, 2023-2030 (USD MILLION) 213
TABLE 246 NORTH AMERICA: BIOBANKING APPLICATIONS MARKET FOR LIFE SCIENCE RESEARCH, BY COUNTRY, 2023-2030 (USD MILLION) 213
TABLE 247 EUROPE: BIOBANKING APPLICATIONS MARKET FOR LIFE SCIENCE RESEARCH,
BY COUNTRY, 2023-2030 (USD MILLION) 213
TABLE 248 ASIA PACIFIC: BIOBANKING APPLICATIONS MARKET FOR LIFE SCIENCE RESEARCH, BY COUNTRY, 2023-2030 (USD MILLION) 214
TABLE 249 LATIN AMERICA: BIOBANKING APPLICATIONS MARKET FOR LIFE SCIENCE RESEARCH, BY COUNTRY, 2023-2030 (USD MILLION) 214
TABLE 250 MIDDLE EAST: BIOBANKING APPLICATIONS MARKET FOR LIFE SCIENCE RESEARCH, BY REGION, 2023-2030 (USD MILLION) 214
TABLE 251 GCC COUNTRIES: BIOBANKING APPLICATIONS MARKET FOR LIFE SCIENCE RESEARCH, BY COUNTRY, 2023-2030 (USD MILLION) 215
TABLE 252 BIOBANKING APPLICATIONS MARKET FOR CLINICAL RESEARCH, BY REGION, 2023-2030 (USD MILLION) 215
TABLE 253 NORTH AMERICA: BIOBANKING APPLICATIONS MARKET FOR CLINICAL RESEARCH, BY COUNTRY, 2023-2030 (USD MILLION) 216
TABLE 254 EUROPE: BIOBANKING APPLICATIONS MARKET FOR CLINICAL RESEARCH,
BY COUNTRY, 2023-2030 (USD MILLION) 216
TABLE 255 ASIA PACIFIC: BIOBANKING APPLICATIONS MARKET FOR CLINICAL RESEARCH,
BY COUNTRY, 2023-2030 (USD MILLION) 216
TABLE 256 LATIN AMERICA: BIOBANKING APPLICATIONS MARKET FOR CLINICAL RESEARCH, BY COUNTRY, 2023-2030 (USD MILLION) 217
TABLE 257 MIDDLE EAST: BIOBANKING APPLICATIONS MARKET FOR CLINICAL RESEARCH,
BY REGION, 2023-2030 (USD MILLION) 217
TABLE 258 GCC COUNTRIES: BIOBANKING APPLICATIONS MARKET FOR CLINICAL RESEARCH, BY COUNTRY, 2023-2030 (USD MILLION) 217
TABLE 259 BIOBANKING MARKET FOR THERAPEUTIC APPLICATIONS, BY REGION,
2023-2030 (USD MILLION) 218
TABLE 260 NORTH AMERICA: BIOBANKING MARKET FOR THERAPEUTIC APPLICATIONS,
BY COUNTRY, 2023-2030 (USD MILLION) 218
TABLE 261 EUROPE: BIOBANKING MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION) 219
TABLE 262 ASIA PACIFIC: BIOBANKING MARKET FOR THERAPEUTIC APPLICATIONS,
BY COUNTRY, 2023-2030 (USD MILLION) 219
TABLE 263 LATIN AMERICA: BIOBANKING MARKET FOR THERAPEUTIC APPLICATIONS,
BY COUNTRY, 2023-2030 (USD MILLION) 219
TABLE 264 MIDDLE EAST: BIOBANKING MARKET FOR THERAPEUTIC APPLICATIONS,
BY REGION, 2023-2030 (USD MILLION) 220
TABLE 265 GCC COUNTRIES: BIOBANKING MARKET FOR THERAPEUTIC APPLICATIONS,
BY COUNTRY, 2023-2030 (USD MILLION) 220
TABLE 266 BIOBANKING MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION,
2023-2030 (USD MILLION) 221
TABLE 267 NORTH AMERICA: BIOBANKING MARKET FOR DIAGNOSTIC APPLICATIONS,
BY COUNTRY, 2023-2030 (USD MILLION) 221
TABLE 268 EUROPE: BIOBANKING MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION) 221
TABLE 269 ASIA PACIFIC: BIOBANKING MARKET FOR DIAGNOSTIC APPLICATIONS,
BY COUNTRY, 2023-2030 (USD MILLION) 222
TABLE 270 LATIN AMERICA: BIOBANKING MARKET FOR DIAGNOSTIC APPLICATIONS,
BY COUNTRY, 2023-2030 (USD MILLION) 222
TABLE 271 MIDDLE EAST: BIOBANKING MARKET FOR DIAGNOSTIC APPLICATIONS,
BY REGION, 2023-2030 (USD MILLION) 222
TABLE 272 GCC COUNTRIES: BIOBANKING MARKET FOR DIAGNOSTIC APPLICATIONS,
BY COUNTRY, 2023-2030 (USD MILLION) 223
TABLE 273 BIOBANKING MARKET FOR OTHER APPLICATIONS, BY REGION,
2023-2030 (USD MILLION) 223
TABLE 274 NORTH AMERICA: BIOBANKING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION) 224
TABLE 275 EUROPE: BIOBANKING MARKET FOR OTHER APPLICATIONS, BY COUNTRY,
2023-2030 (USD MILLION) 224
TABLE 276 ASIA PACIFIC: BIOBANKING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION) 224
TABLE 277 LATIN AMERICA: BIOBANKING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION) 225
TABLE 278 MIDDLE EAST: BIOBANKING MARKET FOR OTHER APPLICATIONS, BY REGION, 2023-2030 (USD MILLION) 225
TABLE 279 GCC COUNTRIES: BIOBANKING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION) 225
TABLE 280 BIOBANKING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION) 227
TABLE 281 PHYSICAL BIOBANKING SERVICES MARKET, BY REGION,
2023-2030 (USD MILLION) 228
TABLE 282 NORTH AMERICA: PHYSICAL BIOBANKING SERVICES MARKET,
BY COUNTRY, 2023-2030 (USD MILLION) 228
TABLE 283 EUROPE: PHYSICAL BIOBANKING SERVICES MARKET, BY COUNTRY,
2023-2030 (USD MILLION) 228
TABLE 284 ASIA PACIFIC: PHYSICAL BIOBANKING SERVICES MARKET, BY COUNTRY,
2023-2030 (USD MILLION) 229
TABLE 285 LATIN AMERICA: PHYSICAL BIOBANKING SERVICES MARKET, BY COUNTRY,
2023-2030 (USD MILLION) 229
TABLE 286 MIDDLE EAST: PHYSICAL BIOBANKING SERVICES MARKET, BY REGION,
2023-2030 (USD MILLION) 229
TABLE 287 GCC COUNTRIES: PHYSICAL BIOBANKING SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION) 230
TABLE 288 VIRTUAL BIOBANKING SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION) 230
TABLE 289 NORTH AMERICA: VIRTUAL BIOBANKING SERVICES MARKET, BY COUNTRY,
2023-2030 (USD MILLION) 231
TABLE 290 EUROPE: VIRTUAL BIOBANKING SERVICES MARKET, BY COUNTRY,
2023-2030 (USD MILLION) 231
TABLE 291 ASIA PACIFIC: VIRTUAL BIOBANKING SERVICES MARKET, BY COUNTRY,
2023-2030 (USD MILLION) 231
TABLE 292 LATIN AMERICA: VIRTUAL BIOBANKING SERVICES MARKET, BY COUNTRY,
2023-2030 (USD MILLION) 232
TABLE 293 MIDDLE EAST: VIRTUAL BIOBANKING SERVICES MARKET, BY REGION,
2023-2030 (USD MILLION) 232
TABLE 294 GCC COUNTRIES: VIRTUAL BIOBANKING SERVICES MARKET, BY COUNTRY,
2023-2030 (USD MILLION) 232
TABLE 295 OTHER BIOBANKING SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION) 233
TABLE 296 NORTH AMERICA: OTHER BIOBANKING SERVICES MARKET, BY COUNTRY,
2023-2030 (USD MILLION) 233
TABLE 297 EUROPE: OTHER BIOBANKING SERVICES MARKET, BY COUNTRY,
2023-2030 (USD MILLION) 234
TABLE 298 ASIA PACIFIC: OTHER BIOBANKING SERVICES MARKET, BY COUNTRY,
2023-2030 (USD MILLION) 234
TABLE 299 LATIN AMERICA: OTHER BIOBANKING SERVICES MARKET, BY COUNTRY,
2023-2030 (USD MILLION) 234
TABLE 300 MIDDLE EAST: OTHER BIOBANKING SERVICES MARKET, BY REGION,
2023-2030 (USD MILLION) 235
TABLE 301 GCC COUNTRIES: OTHER BIOBANKING SERVICES MARKET, BY COUNTRY,
2023-2030 (USD MILLION) 235
TABLE 302 BIOBANKING SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION) 237
TABLE 303 BIOBANKING SERVICES MARKET FOR PHARMA-BIOTECH COMPANIES & CROS,
BY REGION, 2023-2030 (USD MILLION) 238
TABLE 304 NORTH AMERICA: BIOBANKING SERVICES MARKET FOR PHARMA-BIOTECH COMPANIES & CROS, BY COUNTRY, 2023-2030 (USD MILLION) 238
TABLE 305 EUROPE: BIOBANKING SERVICES MARKET FOR PHARMA-BIOTECH COMPANIES & CROS, BY COUNTRY, 2023-2030 (USD MILLION) 238
TABLE 306 ASIA PACIFIC: BIOBANKING SERVICES MARKET FOR PHARMA-BIOTECH COMPANIES & CROS, BY COUNTRY, 2023-2030 (USD MILLION) 239
TABLE 307 LATIN AMERICA: BIOBANKING SERVICES MARKET FOR PHARMA-BIOTECH COMPANIES & CROS, BY COUNTRY, 2023-2030 (USD MILLION) 239
TABLE 308 MIDDLE EAST: BIOBANKING SERVICES MARKET FOR PHARMA-BIOTECH COMPANIES & CROS, BY REGION, 2023-2030 (USD MILLION) 239
TABLE 309 GCC COUNTRIES: BIOBANKING SERVICES MARKET FOR PHARMA-BIOTECH COMPANIES & CROS, BY COUNTRY, 2023-2030 (USD MILLION) 240
TABLE 310 BIOBANKING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023-2030 (USD MILLION) 240
TABLE 311 NORTH AMERICA: BIOBANKING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION) 241
TABLE 312 EUROPE: BIOBANKING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION) 241
TABLE 313 ASIA PACIFIC: BIOBANKING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION) 241
TABLE 314 LATIN AMERICA: BIOBANKING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION) 242
TABLE 315 MIDDLE EAST: BIOBANKING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023-2030 (USD MILLION) 242
TABLE 316 GCC COUNTRIES: BIOBANKING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION) 242
TABLE 317 BIOBANKING SERVICES MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2023-2030 (USD MILLION) 243
TABLE 318 NORTH AMERICA: BIOBANKING SERVICES MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023-2030 (USD MILLION) 243
TABLE 319 EUROPE: BIOBANKING SERVICES MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023-2030 (USD MILLION) 244
TABLE 320 ASIA PACIFIC: BIOBANKING SERVICES MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023-2030 (USD MILLION) 244
TABLE 321 LATIN AMERICA: BIOBANKING SERVICES MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023-2030 (USD MILLION) 244
TABLE 322 MIDDLE EAST: BIOBANKING SERVICES MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2023-2030 (USD MILLION) 245
TABLE 323 GCC COUNTRIES: BIOBANKING SERVICES MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023-2030 (USD MILLION) 245
TABLE 324 BIOBANKING MARKET, BY REGION, 2023-2030 (USD MILLION) 247
TABLE 325 NORTH AMERICA: BIOBANKING MARKET, BY OFFERING,
2023-2030 (USD MILLION) 248
TABLE 326 NORTH AMERICA: BIOBANKING PRODUCTS MARKET, BY TYPE,
2023-2030 (USD MILLION) 249
TABLE 327 NORTH AMERICA: BIOBANKING PRODUCTS MARKET FOR EQUIPMENT,
BY TYPE, 2023-2030 (USD MILLION) 249
TABLE 328 NORTH AMERICA: BIOBANKING EQUIPMENT MARKET, BY OPERATION TYPE,
2023-2030 (USD MILLION) 249
TABLE 329 NORTH AMERICA: BIOBANKING PRODUCTS MARKET, BY WORKFLOW,
2023-2030 (USD MILLION) 250
TABLE 330 NORTH AMERICA: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE,
2023-2030 (USD MILLION) 250
TABLE 331 NORTH AMERICA: BIOBANKING SERVICES MARKET, BY OWNERSHIP,
2023-2030 (USD MILLION) 251
TABLE 332 NORTH AMERICA: BIOBANKING MARKET, BY APPLICATION,
2023-2030 (USD MILLION) 251
TABLE 333 NORTH AMERICA: BIOBANKING MARKET FOR RESEARCH APPLICATIONS,
BY TYPE, 2023-2030 (USD MILLION) 251
TABLE 334 NORTH AMERICA: BIOBANKING PRODUCTS MARKET, BY END USER,
2023-2030 (USD MILLION) 252
TABLE 335 NORTH AMERICA: BIOBANKING SERVICES MARKET, BY END USER,
2023-2030 (USD MILLION) 252
TABLE 336 NORTH AMERICA: BIOBANKING MARKET, BY COUNTRY,
2023-2030 (USD MILLION) 252
TABLE 337 NORTH AMERICA: KEY MACROINDICATORS 253
TABLE 338 US: BIOBANKING MARKET, BY OFFERING, 2023-2030 (USD MILLION) 254
TABLE 339 US: BIOBANKING PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION) 254
TABLE 340 US: BIOBANKING PRODUCTS MARKET FOR EQUIPMENT, BY TYPE,
2023-2030 (USD MILLION) 255
TABLE 341 US: BIOBANKING EQUIPMENT MARKET, BY OPERATION TYPE,
2023-2030 (USD MILLION) 255
TABLE 342 US: BIOBANKING PRODUCTS MARKET, BY WORKFLOW,
2023-2030 (USD MILLION) 255
TABLE 343 US: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE,
2023-2030 (USD MILLION) 256
TABLE 344 US: BIOBANKING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION) 256
TABLE 345 US: BIOBANKING SERVICES MARKET, BY OWNERSHIP, 2023-2030 (USD MILLION) 256
TABLE 346 US: BIOBANKING MARKET, BY APPLICATION, 2023-2030 (USD MILLION) 257
TABLE 347 US: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY TYPE,
2023-2030 (USD MILLION) 257
TABLE 348 US: BIOBANKING PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION) 257
TABLE 349 US: BIOBANKING SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION) 258
TABLE 350 CANADA: BIOBANKING MARKET, BY OFFERING, 2023-2030 (USD MILLION) 258
TABLE 351 CANADA: BIOBANKING PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION) 259
TABLE 352 CANADA: BIOBANKING PRODUCTS MARKET FOR EQUIPMENT, BY TYPE,
2023-2030 (USD MILLION) 259
TABLE 353 CANADA: BIOBANKING EQUIPMENT MARKET, BY OPERATION TYPE,
2023-2030 (USD MILLION) 259
TABLE 354 CANADA: BIOBANKING PRODUCTS MARKET, BY WORKFLOW,
2023-2030 (USD MILLION) 260
TABLE 355 CANADA: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE,
2023-2030 (USD MILLION) 260
TABLE 356 CANADA: BIOBANKING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION) 260
TABLE 357 CANADA: BIOBANKING SERVICES MARKET, BY OWNERSHIP,
2023-2030 (USD MILLION) 261
TABLE 358 CANADA: BIOBANKING MARKET, BY APPLICATION, 2023-2030 (USD MILLION) 261
TABLE 359 CANADA: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY TYPE,
2023-2030 (USD MILLION) 261
TABLE 360 CANADA: BIOBANKING PRODUCTS MARKET, BY END USER,
2023-2030 (USD MILLION) 262
TABLE 361 CANADA: BIOBANKING SERVICES MARKET, BY END USER,
2023-2030 (USD MILLION) 262
TABLE 362 EUROPE: BIOBANKING MARKET, BY OFFERING, 2023-2030 (USD MILLION) 263
TABLE 363 EUROPE: BIOBANKING PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION) 263
TABLE 364 EUROPE: BIOBANKING PRODUCTS MARKET FOR EQUIPMENT, BY TYPE,
2023-2030 (USD MILLION) 263
TABLE 365 EUROPE: BIOBANKING EQUIPMENT MARKET, BY OPERATION TYPE,
2023-2030 (USD MILLION) 264
TABLE 366 EUROPE: BIOBANKING PRODUCTS MARKET, BY WORKFLOW,
2023-2030 (USD MILLION) 264
TABLE 367 EUROPE: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE,
2023-2030 (USD MILLION) 264
TABLE 368 EUROPE: BIOBANKING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION) 265
TABLE 369 EUROPE: BIOBANKING SERVICES MARKET, BY OWNERSHIP,
2023-2030 (USD MILLION) 265
TABLE 370 EUROPE: BIOBANKING MARKET, BY APPLICATION, 2023-2030 (USD MILLION) 265
TABLE 371 EUROPE: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY TYPE,
2023-2030 (USD MILLION) 266
TABLE 372 EUROPE: BIOBANKING PRODUCTS MARKET, BY END USER,
2023-2030 (USD MILLION) 266
TABLE 373 EUROPE: BIOBANKING SERVICES MARKET, BY END USER,
2023-2030 (USD MILLION) 266
TABLE 374 EUROPE: BIOBANKING MARKET, BY COUNTRY, 2023-2030 (USD MILLION) 267
TABLE 375 EUROPE: KEY MACROINDICATORS 268
TABLE 376 GERMANY: BIOBANKING MARKET, BY OFFERING, 2023-2030 (USD MILLION) 269
TABLE 377 GERMANY: BIOBANKING PRODUCTS MARKET, BY TYPE,
2023-2030 (USD MILLION) 269
TABLE 378 GERMANY: BIOBANKING PRODUCTS MARKET FOR EQUIPMENT, BY TYPE,
2023-2030 (USD MILLION) 269
TABLE 379 GERMANY: BIOBANKING EQUIPMENT MARKET, BY OPERATION TYPE,
2023-2030 (USD MILLION) 270
TABLE 380 GERMANY: BIOBANKING PRODUCTS MARKET, BY WORKFLOW,
2023-2030 (USD MILLION) 270
TABLE 381 GERMANY: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE,
2023-2030 (USD MILLION) 270
TABLE 382 GERMANY: BIOBANKING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION) 271
TABLE 383 GERMANY: BIOBANKING SERVICES MARKET, BY OWNERSHIP,
2023-2030 (USD MILLION) 271
TABLE 384 GERMANY: BIOBANKING MARKET, BY APPLICATION, 2023-2030 (USD MILLION) 271
TABLE 385 GERMANY: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY TYPE,
2023-2030 (USD MILLION) 272
TABLE 386 GERMANY: BIOBANKING PRODUCTS MARKET, BY END USER,
2023-2030 (USD MILLION) 272
TABLE 387 GERMANY: BIOBANKING SERVICES MARKET, BY END USER,
2023-2030 (USD MILLION) 272
TABLE 388 UK: BIOBANKING MARKET, BY OFFERING, 2023-2030 (USD MILLION) 273
TABLE 389 UK: BIOBANKING PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION) 273
TABLE 390 UK: BIOBANKING PRODUCTS MARKET FOR EQUIPMENT, BY TYPE,
2023-2030 (USD MILLION) 274
TABLE 391 UK: BIOBANKING EQUIPMENT MARKET, BY OPERATION TYPE,
2023-2030 (USD MILLION) 274
TABLE 392 UK: BIOBANKING PRODUCTS MARKET, BY WORKFLOW,
2023-2030 (USD MILLION) 274
TABLE 393 UK: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE,
2023-2030 (USD MILLION) 275
TABLE 394 UK: BIOBANKING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION) 275
TABLE 395 UK: BIOBANKING SERVICES MARKET, BY OWNERSHIP, 2023-2030 (USD MILLION) 275
TABLE 396 UK: BIOBANKING MARKET, BY APPLICATION, 2023-2030 (USD MILLION) 276
TABLE 397 UK: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY TYPE,
2023-2030 (USD MILLION) 276
TABLE 398 UK: BIOBANKING PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION) 276
TABLE 399 UK: BIOBANKING SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION) 277
TABLE 400 FRANCE: BIOBANKING MARKET, BY OFFERING, 2023-2030 (USD MILLION) 277
TABLE 401 FRANCE: BIOBANKING PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION) 278
TABLE 402 FRANCE: BIOBANKING PRODUCTS MARKET FOR EQUIPMENT, BY TYPE,
2023-2030 (USD MILLION) 278
TABLE 403 FRANCE: BIOBANKING EQUIPMENT MARKET, BY OPERATION TYPE,
2023-2030 (USD MILLION) 278
TABLE 404 FRANCE: BIOBANKING PRODUCTS MARKET, BY WORKFLOW,
2023-2030 (USD MILLION) 279
TABLE 405 FRANCE: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE,
2023-2030 (USD MILLION) 279
TABLE 406 FRANCE: BIOBANKING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION) 279
TABLE 407 FRANCE: BIOBANKING SERVICES MARKET, BY OWNERSHIP,
2023-2030 (USD MILLION) 280
TABLE 408 FRANCE: BIOBANKING MARKET, BY APPLICATION, 2023-2030 (USD MILLION) 280
TABLE 409 FRANCE: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY TYPE,
2023-2030 (USD MILLION) 280
TABLE 410 FRANCE: BIOBANKING PRODUCTS MARKET, BY END USER,
2023-2030 (USD MILLION) 281
TABLE 411 FRANCE: BIOBANKING SERVICES MARKET, BY END USER,
2023-2030 (USD MILLION) 281
TABLE 412 ITALY: BIOBANKING MARKET, BY OFFERING, 2023-2030 (USD MILLION) 282
TABLE 413 ITALY: BIOBANKING PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION) 282
TABLE 414 ITALY: BIOBANKING PRODUCTS MARKET FOR EQUIPMENT, BY TYPE,
2023-2030 (USD MILLION) 282
TABLE 415 ITALY: BIOBANKING EQUIPMENT MARKET, BY OPERATION TYPE,
2023-2030 (USD MILLION) 283
TABLE 416 ITALY: BIOBANKING PRODUCTS MARKET, BY WORKFLOW,
2023-2030 (USD MILLION) 283
TABLE 417 ITALY: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE,
2023-2030 (USD MILLION) 283
TABLE 418 ITALY: BIOBANKING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION) 284
TABLE 419 ITALY: BIOBANKING SERVICES MARKET, BY OWNERSHIP,
2023-2030 (USD MILLION) 284
TABLE 420 ITALY: BIOBANKING MARKET, BY APPLICATION, 2023-2030 (USD MILLION) 284
TABLE 421 ITALY: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY TYPE,
2023-2030 (USD MILLION) 285
TABLE 422 ITALY: BIOBANKING PRODUCTS MARKET, BY END USER,
2023-2030 (USD MILLION) 285
TABLE 423 ITALY: BIOBANKING SERVICES MARKET, BY END USER,
2023-2030 (USD MILLION) 285
TABLE 424 SPAIN: BIOBANKING MARKET, BY OFFERING, 2023-2030 (USD MILLION) 286
TABLE 425 SPAIN: BIOBANKING PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION) 286
TABLE 426 SPAIN: BIOBANKING PRODUCTS MARKET FOR EQUIPMENT, BY TYPE,
2023-2030 (USD MILLION) 287
TABLE 427 SPAIN: BIOBANKING EQUIPMENT MARKET, BY OPERATION TYPE,
2023-2030 (USD MILLION) 287
TABLE 428 SPAIN: BIOBANKING PRODUCTS MARKET, BY WORKFLOW,
2023-2030 (USD MILLION) 287
TABLE 429 SPAIN: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE,
2023-2030 (USD MILLION) 288
TABLE 430 SPAIN: BIOBANKING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION) 288
TABLE 431 SPAIN: BIOBANKING SERVICES MARKET, BY OWNERSHIP,
2023-2030 (USD MILLION) 288
TABLE 432 SPAIN: BIOBANKING MARKET, BY APPLICATION, 2023-2030 (USD MILLION) 289
TABLE 433 SPAIN: BIOBANKING MARKET FOR RESEARCH APPLICATIONS,
BY TYPE, 2023-2030 (USD MILLION) 289
TABLE 434 SPAIN: BIOBANKING PRODUCTS MARKET, BY END USER,
2023-2030 (USD MILLION) 289
TABLE 435 SPAIN: BIOBANKING SERVICES MARKET, BY END USER,
2023-2030 (USD MILLION) 290
TABLE 436 REST OF EUROPE: BIOBANKING MARKET, BY OFFERING,
2023-2030 (USD MILLION) 290
TABLE 437 REST OF EUROPE: BIOBANKING PRODUCTS MARKET, BY TYPE,
2023-2030 (USD MILLION) 291
TABLE 438 REST OF EUROPE: BIOBANKING PRODUCTS MARKET FOR EQUIPMENT,
BY TYPE, 2023-2030 (USD MILLION) 291
TABLE 439 REST OF EUROPE: BIOBANKING EQUIPMENT MARKET, BY OPERATION TYPE, 2023-2030 (USD MILLION) 291
TABLE 440 REST OF EUROPE: BIOBANKING PRODUCTS MARKET, BY WORKFLOW,
2023-2030 (USD MILLION) 292
TABLE 441 REST OF EUROPE: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE,
2023-2030 (USD MILLION) 292
TABLE 442 REST OF EUROPE: BIOBANKING SERVICES MARKET, BY TYPE,
2023-2030 (USD MILLION) 292
TABLE 443 REST OF EUROPE: BIOBANKING SERVICES MARKET, BY OWNERSHIP,
2023-2030 (USD MILLION) 293
TABLE 444 REST OF EUROPE: BIOBANKING MARKET, BY APPLICATION,
2023-2030 (USD MILLION) 293
TABLE 445 REST OF EUROPE: BIOBANKING MARKET FOR RESEARCH APPLICATIONS,
BY TYPE, 2023-2030 (USD MILLION) 293
TABLE 446 REST OF EUROPE: BIOBANKING PRODUCTS MARKET, BY END USER,
2023-2030 (USD MILLION) 294
TABLE 447 REST OF EUROPE: BIOBANKING SERVICES MARKET, BY END USER,
2023-2030 (USD MILLION) 294
TABLE 448 ASIA PACIFIC: BIOBANKING MARKET, BY OFFERING, 2023-2030 (USD MILLION) 295
TABLE 449 ASIA PACIFIC: BIOBANKING PRODUCTS MARKET, BY TYPE,
2023-2030 (USD MILLION) 296
TABLE 450 ASIA PACIFIC: BIOBANKING PRODUCTS MARKET FOR EQUIPMENT, BY TYPE,
2023-2030 (USD MILLION) 296
TABLE 451 ASIA PACIFIC: BIOBANKING EQUIPMENT MARKET, BY OPERATION TYPE,
2023-2030 (USD MILLION) 296
TABLE 452 ASIA PACIFIC: BIOBANKING PRODUCTS MARKET, BY WORKFLOW,
2023-2030 (USD MILLION) 297
TABLE 453 ASIA PACIFIC: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE,
2023-2030 (USD MILLION) 297
TABLE 454 ASIA PACIFIC: BIOBANKING SERVICES MARKET, BY TYPE,
2023-2030 (USD MILLION) 297
TABLE 455 ASIA PACIFIC: BIOBANKING SERVICES MARKET, BY OWNERSHIP,
2023-2030 (USD MILLION) 298
TABLE 456 ASIA PACIFIC: BIOBANKING MARKET, BY APPLICATION, 2023-2030 (USD MILLION) 298
TABLE 457 ASIA PACIFIC: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION) 298
TABLE 458 ASIA PACIFIC: BIOBANKING PRODUCTS MARKET, BY END USER,
2023-2030 (USD MILLION) 299
TABLE 459 ASIA PACIFIC: BIOBANKING SERVICES MARKET, BY END USER,
2023-2030 (USD MILLION) 299
TABLE 460 ASIA PACIFIC: BIOBANKING MARKET, BY COUNTRY, 2023-2030 (USD MILLION) 299
TABLE 461 ASIA PACIFIC: KEY MACROINDICATORS 300
TABLE 462 CHINA: BIOBANKING MARKET, BY OFFERING, 2023-2030 (USD MILLION) 301
TABLE 463 CHINA: BIOBANKING PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION) 301
TABLE 464 CHINA: BIOBANKING PRODUCTS MARKET FOR EQUIPMENT, BY TYPE,
2023-2030 (USD MILLION) 302
TABLE 465 CHINA: BIOBANKING EQUIPMENT MARKET, BY OPERATION TYPE,
2023-2030 (USD MILLION) 302
TABLE 466 CHINA: BIOBANKING PRODUCTS MARKET, BY WORKFLOW,
2023-2030 (USD MILLION) 302
TABLE 467 CHINA: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE,
2023-2030 (USD MILLION) 303
TABLE 468 CHINA: BIOBANKING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION) 303
TABLE 469 CHINA: BIOBANKING SERVICES MARKET, BY OWNERSHIP,
2023-2030 (USD MILLION) 303
TABLE 470 CHINA: BIOBANKING MARKET, BY APPLICATION, 2023-2030 (USD MILLION) 304
TABLE 471 CHINA: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY TYPE,
2023-2030 (USD MILLION) 304
TABLE 472 CHINA: BIOBANKING PRODUCTS MARKET, BY END USER,
2023-2030 (USD MILLION) 304
TABLE 473 CHINA: BIOBANKING SERVICES MARKET, BY END USER,
2023-2030 (USD MILLION) 305
TABLE 474 JAPAN: BIOBANKING MARKET, BY OFFERING, 2023-2030 (USD MILLION) 305
TABLE 475 JAPAN: BIOBANKING PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION) 306
TABLE 476 JAPAN: BIOBANKING PRODUCTS MARKET FOR EQUIPMENT, BY TYPE,
2023-2030 (USD MILLION) 306
TABLE 477 JAPAN: BIOBANKING EQUIPMENT MARKET, BY OPERATION TYPE,
2023-2030 (USD MILLION) 306
TABLE 478 JAPAN: BIOBANKING PRODUCTS MARKET, BY WORKFLOW,
2023-2030 (USD MILLION) 307
TABLE 479 JAPAN: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE,
2023-2030 (USD MILLION) 307
TABLE 480 JAPAN: BIOBANKING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION) 307
TABLE 481 JAPAN: BIOBANKING SERVICES MARKET, BY OWNERSHIP,
2023-2030 (USD MILLION) 308
TABLE 482 JAPAN: BIOBANKING MARKET, BY APPLICATION, 2023-2030 (USD MILLION) 308
TABLE 483 JAPAN: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY TYPE,
2023-2030 (USD MILLION) 308
TABLE 484 JAPAN: BIOBANKING PRODUCTS MARKET, BY END USER,
2023-2030 (USD MILLION) 309
TABLE 485 JAPAN: BIOBANKING SERVICES MARKET, BY END USER,
2023-2030 (USD MILLION) 309
TABLE 486 INDIA: BIOBANKING MARKET, BY OFFERING, 2023-2030 (USD MILLION) 310
TABLE 487 INDIA: BIOBANKING PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION) 310
TABLE 488 INDIA: BIOBANKING PRODUCTS MARKET FOR EQUIPMENT, BY TYPE,
2023-2030 (USD MILLION) 310
TABLE 489 INDIA: BIOBANKING EQUIPMENT MARKET, BY OPERATION TYPE,
2023-2030 (USD MILLION) 311
TABLE 490 INDIA: BIOBANKING PRODUCTS MARKET, BY WORKFLOW,
2023-2030 (USD MILLION) 311
TABLE 491 INDIA: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE,
2023-2030 (USD MILLION) 311
TABLE 492 INDIA: BIOBANKING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION) 312
TABLE 493 INDIA: BIOBANKING SERVICES MARKET, BY OWNERSHIP,
2023-2030 (USD MILLION) 312
TABLE 494 INDIA: BIOBANKING MARKET, BY APPLICATION, 2023-2030 (USD MILLION) 312
TABLE 495 INDIA: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY TYPE,
2023-2030 (USD MILLION) 313
TABLE 496 INDIA: BIOBANKING PRODUCTS MARKET, BY END USER,
2023-2030 (USD MILLION) 313
TABLE 497 INDIA: BIOBANKING SERVICES MARKET, BY END USER,
2023-2030 (USD MILLION) 313
TABLE 498 AUSTRALIA: BIOBANKING MARKET, BY OFFERING, 2023-2030 (USD MILLION) 314
TABLE 499 AUSTRALIA: BIOBANKING PRODUCTS MARKET, BY TYPE,
2023-2030 (USD MILLION) 314
TABLE 500 AUSTRALIA: BIOBANKING PRODUCTS MARKET FOR EQUIPMENT, BY TYPE,
2023-2030 (USD MILLION) 315
TABLE 501 AUSTRALIA: BIOBANKING EQUIPMENT MARKET, BY OPERATION TYPE,
2023-2030 (USD MILLION) 315
TABLE 502 AUSTRALIA: BIOBANKING PRODUCTS MARKET, BY WORKFLOW,
2023-2030 (USD MILLION) 315
TABLE 503 AUSTRALIA: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE,
2023-2030 (USD MILLION) 316
TABLE 504 AUSTRALIA: BIOBANKING SERVICES MARKET, BY TYPE,
2023-2030 (USD MILLION) 316
TABLE 505 AUSTRALIA: BIOBANKING SERVICES MARKET, BY OWNERSHIP,
2023-2030 (USD MILLION) 317
TABLE 506 AUSTRALIA: BIOBANKING MARKET, BY APPLICATION, 2023-2030 (USD MILLION) 317
TABLE 507 AUSTRALIA: BIOBANKING MARKET FOR RESEARCH APPLICATIONS,
BY TYPE, 2023-2030 (USD MILLION) 317
TABLE 508 AUSTRALIA: BIOBANKING PRODUCTS MARKET, BY END USER,
2023-2030 (USD MILLION) 318
TABLE 509 AUSTRALIA: BIOBANKING SERVICES MARKET, BY END USER,
2023-2030 (USD MILLION) 318
TABLE 510 SOUTH KOREA: BIOBANKING MARKET, BY OFFERING, 2023-2030 (USD MILLION) 319
TABLE 511 SOUTH KOREA: BIOBANKING PRODUCTS MARKET, BY TYPE,
2023-2030 (USD MILLION) 319
TABLE 512 SOUTH KOREA: BIOBANKING PRODUCTS MARKET FOR EQUIPMENT, BY TYPE, 2023-2030 (USD MILLION) 319
TABLE 513 SOUTH KOREA: BIOBANKING EQUIPMENT MARKET, BY OPERATION TYPE,
2023-2030 (USD MILLION) 320
TABLE 514 SOUTH KOREA: BIOBANKING PRODUCTS MARKET, BY WORKFLOW,
2023-2030 (USD MILLION) 320
TABLE 515 SOUTH KOREA: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE,
2023-2030 (USD MILLION) 320
TABLE 516 SOUTH KOREA: BIOBANKING SERVICES MARKET, BY TYPE,
2023-2030 (USD MILLION) 321
TABLE 517 SOUTH KOREA: BIOBANKING SERVICES MARKET, BY OWNERSHIP,
2023-2030 (USD MILLION) 321
TABLE 518 SOUTH KOREA: BIOBANKING MARKET, BY APPLICATION,
2023-2030 (USD MILLION) 321
TABLE 519 SOUTH KOREA: BIOBANKING MARKET FOR RESEARCH APPLICATIONS,
BY TYPE, 2023-2030 (USD MILLION) 322
TABLE 520 SOUTH KOREA: BIOBANKING PRODUCTS MARKET, BY END USER,
2023-2030 (USD MILLION) 322
TABLE 521 SOUTH KOREA: BIOBANKING SERVICES MARKET, BY END USER,
2023-2030 (USD MILLION) 322
TABLE 522 REST OF ASIA PACIFIC: BIOBANKING MARKET, BY OFFERING,
2023-2030 (USD MILLION) 323
TABLE 523 REST OF ASIA PACIFIC: BIOBANKING PRODUCTS MARKET, BY TYPE,
2023-2030 (USD MILLION) 323
TABLE 524 REST OF ASIA PACIFIC: BIOBANKING PRODUCTS MARKET FOR EQUIPMENT,
BY TYPE, 2023-2030 (USD MILLION) 324
TABLE 525 REST OF ASIA PACIFIC: BIOBANKING EQUIPMENT MARKET, BY OPERATION TYPE, 2023-2030 (USD MILLION) 324
TABLE 526 REST OF ASIA PACIFIC: BIOBANKING PRODUCTS MARKET, BY WORKFLOW,
2023-2030 (USD MILLION) 324
TABLE 527 REST OF ASIA PACIFIC: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE, 2023-2030 (USD MILLION) 325
TABLE 528 REST OF ASIA PACIFIC: BIOBANKING SERVICES MARKET, BY TYPE,
2023-2030 (USD MILLION) 325
TABLE 529 REST OF ASIA PACIFIC: BIOBANKING SERVICES MARKET, BY OWNERSHIP,
2023-2030 (USD MILLION) 326
TABLE 530 REST OF ASIA PACIFIC: BIOBANKING MARKET, BY APPLICATION,
2023-2030 (USD MILLION) 326
TABLE 531 REST OF ASIA PACIFIC: BIOBANKING MARKET FOR RESEARCH APPLICATIONS,
BY TYPE, 2023-2030 (USD MILLION) 326
TABLE 532 REST OF ASIA PACIFIC: BIOBANKING PRODUCTS MARKET, BY END USER,
2023-2030 (USD MILLION) 327
TABLE 533 REST OF ASIA PACIFIC: BIOBANKING SERVICES MARKET, BY END USER,
2023-2030 (USD MILLION) 327
TABLE 534 LATIN AMERICA: BIOBANKING MARKET, BY OFFERING, 2023-2030 (USD MILLION) 328
TABLE 535 LATIN AMERICA: BIOBANKING PRODUCTS MARKET, BY TYPE,
2023-2030 (USD MILLION) 328
TABLE 536 LATIN AMERICA: BIOBANKING PRODUCTS MARKET FOR EQUIPMENT,
BY TYPE, 2023-2030 (USD MILLION) 328
TABLE 537 LATIN AMERICA: BIOBANKING EQUIPMENT MARKET, BY OPERATION TYPE,
2023-2030 (USD MILLION) 329
TABLE 538 LATIN AMERICA: BIOBANKING PRODUCTS MARKET, BY WORKFLOW,
2023-2030 (USD MILLION) 329
TABLE 539 LATIN AMERICA: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE,
2023-2030 (USD MILLION) 329
TABLE 540 LATIN AMERICA: BIOBANKING SERVICES MARKET, BY TYPE,
2023-2030 (USD MILLION) 330
TABLE 541 LATIN AMERICA: BIOBANKING SERVICES MARKET, BY OWNERSHIP,
2023-2030 (USD MILLION) 330
TABLE 542 LATIN AMERICA: BIOBANKING MARKET, BY APPLICATION,
2023-2030 (USD MILLION) 330
TABLE 543 LATIN AMERICA: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION) 331
TABLE 544 LATIN AMERICA: BIOBANKING PRODUCTS MARKET, BY END USER,
2023-2030 (USD MILLION) 331
TABLE 545 LATIN AMERICA: BIOBANKING SERVICES MARKET, BY END USER,
2023-2030 (USD MILLION) 331
TABLE 546 LATIN AMERICA: BIOBANKING SERVICES MARKET, BY COUNTRY,
2023-2030 (USD MILLION) 332
TABLE 547 LATIN AMERICA: KEY MACROINDICATORS 333
TABLE 548 BRAZIL: BIOBANKING MARKET, BY OFFERING, 2023-2030 (USD MILLION) 333
TABLE 549 BRAZIL: BIOBANKING PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION) 334
TABLE 550 BRAZIL: BIOBANKING PRODUCTS MARKET FOR EQUIPMENT, BY TYPE,
2023-2030 (USD MILLION) 334
TABLE 551 BRAZIL: BIOBANKING EQUIPMENT MARKET, BY OPERATION TYPE,
2023-2030 (USD MILLION) 334
TABLE 552 BRAZIL: BIOBANKING PRODUCTS MARKET, BY WORKFLOW,
2023-2030 (USD MILLION) 335
TABLE 553 BRAZIL: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE,
2023-2030 (USD MILLION) 335
TABLE 554 BRAZIL: BIOBANKING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION) 335
TABLE 555 BRAZIL: BIOBANKING SERVICES MARKET, BY OWNERSHIP,
2023-2030 (USD MILLION) 336
TABLE 556 BRAZIL: BIOBANKING MARKET, BY APPLICATION, 2023-2030 (USD MILLION) 336
TABLE 557 BRAZIL: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY TYPE,
2023-2030 (USD MILLION) 336
TABLE 558 BRAZIL: BIOBANKING PRODUCTS MARKET, BY END USER,
2023-2030 (USD MILLION) 337
TABLE 559 BRAZIL: BIOBANKING SERVICES MARKET, BY END USER,
2023-2030 (USD MILLION) 337
TABLE 560 MEXICO: BIOBANKING MARKET, BY OFFERING, 2023-2030 (USD MILLION) 338
TABLE 561 MEXICO: BIOBANKING PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION) 338
TABLE 562 MEXICO: BIOBANKING PRODUCTS MARKET FOR EQUIPMENT,
BY TYPE, 2023-2030 (USD MILLION) 338
TABLE 563 MEXICO: BIOBANKING EQUIPMENT MARKET, BY OPERATION TYPE,
2023-2030 (USD MILLION) 339
TABLE 564 MEXICO: BIOBANKING PRODUCTS MARKET, BY WORKFLOW,
2023-2030 (USD MILLION) 339
TABLE 565 MEXICO: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE,
2023-2030 (USD MILLION) 339
TABLE 566 MEXICO: BIOBANKING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION) 340
TABLE 567 MEXICO: BIOBANKING SERVICES MARKET, BY OWNERSHIP,
2023-2030 (USD MILLION) 340
TABLE 568 MEXICO: BIOBANKING MARKET, BY APPLICATION, 2023-2030 (USD MILLION) 340
TABLE 569 MEXICO: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY TYPE,
2023-2030 (USD MILLION) 341
TABLE 570 MEXICO: BIOBANKING PRODUCTS MARKET, BY END USER,
2023-2030 (USD MILLION) 341
TABLE 571 MEXICO: BIOBANKING SERVICES MARKET, BY END USER,
2023-2030 (USD MILLION) 341
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security